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Abstract  
One of the most serious problems of the modern medicine is the 
growing emergence of antibiotic resistance among pathogenic 
bacteria. In this circumstance, different and innovative approaches 
for treating infections caused by multidrug-resistant bacteria are 
imperatively required. Bacteriophage Therapy is one among the 
fascinating approaches to be taken into account. This consists of the 
use of bacteriophages, viruses that infect bacteria, in order to defeat 
specific bacterial pathogens. Phage therapy is not an innovative 
idea, indeed, it was widely used around the world in the 1930s and 
1940s, in order to treat various infection diseases, and it is still used 
in Eastern Europe and the former Soviet Union. Nevertheless, 
Western scientists mostly lost interest in further use and study of 
phage therapy and abandoned it after the discovery and the spread 
of antibiotics. The advancement of scientific knowledge of the last 
years, together with the encouraging results from recent animal 
studies using phages to treat bacterial infections, and above all the 
urgent need for novel and effective antimicrobials, have given a 
prompt for additional rigorous researches in this field. In particular, 
in the laboratory of synthetic biology of the department of Life 
Sciences at the University of Warwick, a novel approach was 
adopted, starting from the original concept of phage therapy, in 
order to study a concrete alternative to antibiotics. The innovative 
idea of the project consists in the development of experimental 
methodologies, which allow to engineer a programmable synthetic 
phage system using a combination of directed evolution, 
automation and microfluidics. The main aim is to make “the 
therapeutics of tomorrow individualized, specific, and self-
regulated” (Jaramillo, 2015). In this context, one of the most 
important key points is the Bacteriophage Quantification.  
Therefore, in this research work, a mathematical model describing 
complex dynamics occurring in biological systems involving 
continuous growth of bacteriophages, modulated by the 
performance of the host organisms, was implemented as algorithms 
into a working software using MATLAB. The developed program 
is able to predict different unknown concentrations of phages much 
faster than the classical overnight Plaque Assay. What is more, it 
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gives a meaning and an explanation to the obtained data, making 
inference about the parameter set of the model, that are 
representative of the bacteriophage-host interaction.    
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Introduction  
Phage therapy is the use of bacteriophages, also known as phages, 
as antimicrobial agents for the treatment of pathogenic bacteria and 
other problems. In recent years, the recognition of a phenomenon 
antibiotic resistance as a major healthcare issue has led to renew 
interest in alternative therapies including bacteriophage therapy 
(Merril & Adhya, 2003; Hanlon GW, 2007). The project of 
Professor Alfonso Jaramillo’s laboratory at the University of 
Warwick is part of this research orientation. In particular, its main 
purpose is the continuous production and directed evolution of 
synthetic bacteriophage cocktails using techniques and technologies 
that come from Biology, Chemistry and Engineering.  In this 
context, one of the issues and urgencies is the phage quantification, 
in other words, the determination of the phage concentration. The 
classical method for the count of the number of phages, or simply 
the Phage Titer, is the Bacteriophage Plaques Assay. However, in 
order to have some results with this technique, it is necessary to 
await up to 24 hours.  
 
In this thesis, a delay model was implemented and solved in Matlab 
environment, in order to obtain a faster prediction and 
quantification of a specific unknown concentration of phages and to 
make inference about the model parameters. The first chapter 
provides a succinct description of bacteria and bacteriophages, the 
basic interactions among them and the reason why the scientific 
research has focused the attention again on the phage therapy. In 
the second chapter, mathematical models which represent the 
dynamics of Bacteriophage-Host interaction are described in detail. 
The experimental techniques adopted and the architecture of the 
software implementation are examined in the third chapter. The 
experimental details and results are reported in the fourth chapter. 
Finally, the conclusion of the work are summarised in the last 
chapter. 
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Chapter 1:  
1 The protagonists of Bacteriophage 
therapy 
1.1 Bacteria 
 
Due to the presence of a rigid wall, bacteria maintain a definite 
shape. However, bacteria come in a wide variety of shapes, sizes 
and structures and most of them are very small, in the order of a 
few micrometers (10
-6 
meters). The most common shapes are the 
rod-like (Bacillus), the spherical (Coccus), and the spiral (Spiral) 
(Figure 1).   
 
 
Figure 1: Most bacteria have diameters in the range of 1 µm (micrometre) to 5 µm. From left to 
right: Spherical (cocci) bacteria, rod-shaped (bacilli) bacteria, Spiral bacteria. 
(http://www.ppdictionary.com/gnbac.htm) 
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A second major criterion for distinguishing bacteria is based on the 
cell wall structure. Using a series of stains and reagents called the 
Gram stain, the cells wall can give different staining characteristics. 
In particular, with this method of differentiation, bacteria that have 
a thin layer and an outer membrane stain red are called Gram 
negative while bacteria with a thicker wall layer, lacking the outer 
membrane, stain violet are called Gram positive. 
 
1.1.1 Bacterial growth 
Most bacteria share one major characteristic: they reproduce by an 
asexual process called “binary fission” (Figure 2). This means that 
the cell elongates and grows to about double its original size and 
then splits, after the equal division of the nuclear materials, into two 
genetically identical daughter cells called clones. 
Growing bacteria on a solid surface as agar on a Petri dish, it is 
possible to distinguish different colonies. A colony is composed by 
all the progeny of a single original cell. 
 
 
Figure 2: Bacteria during the process of binary fission. 
(http://www.sflorg.com/sciencenews/scn061606_01.html) 
 
It is simple to note that the mathematical series describing bacterial 
growth is: 1, 2, 4, 8, 16, etc. It can be also written as a series in base 
2: 2
0
, 2
1
, 2
2
, 2
3
, 2
4
, etc. For this reason, bacteria show an 
exponential growth since the number that increases in the series is 
the exponent. In reality, exponential growth is only one phase of the 
bacterial life cycle.  
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When a given number of bacteria is inoculated in a close system (or 
batch culture), like a test tube with fresh medium, it is possible to 
monitor the population growth trend over time. The graph that plots 
cell number versus time is called bacterial growth curve and usually 
the cell number is expressed as a log. In a growing culture, the plot 
gives a characteristic curve in which four phases of the bacterial 
growth cycle are distinguished: lag phase, exponential (log) phase, 
stationary phase, and death phase (Figure 3). 
 
The lag phase is the first phase observed. Immediately after 
inoculation of bacteria into a new growth medium, there is no 
change in the cell number. However, the population can grow in 
volume or mass, synthesizing proteins, RNA, etc., and increase in 
metabolic activity in preparation for the cell division.  The lag 
phase may be short or very long; its duration depends on several 
factors including recovery time necessary after the shock and/or 
damage in the transfer; time required for the production of division 
factors; and the quantity of the starting inoculum. 
 
During the second phase called exponential or log phase, the cells 
begin DNA replication and shortly after they divide by binary 
fission. This is the period where the cells can grow most quickly, 
with a geometric progression. The time necessary for the culture to 
double is called “generation (or doubling) time”. This is 
represented as a fairly constant rate and it can be easily obtained 
from the graph. The exponential growth leads to rapidly increasing 
population but it cannot last forever in a batch culture because of 
the exhaustion of available nutrients; accumulation of end products 
and inhibitory metabolites; lack of “biological space” due to the 
increase of the population density. 
 
The third phase in the bacterial growth is the stationary phase, that 
is not necessarily a period of quiescence. During this phase bacteria 
can divide slowly for a time, but soon stop dividing completely. 
Viable cells counted maintain a slow metabolic activity; if they are 
diluted into fresh medium they can quickly adopt again an 
exponential growth. 
 
In the last phase, if there is no addition of new medium, the number 
of viable cells progressively decreases. Like the log phase, the 
death phase follows an exponential trend and within hours the 
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culture may not have any living cells. It is important to underline 
that most of dead bacteria look identical to live cells, so normal 
spectrophotometer measurements or microscopic count are not an 
indication of the observation of live cells. Hence, in order to have a 
culture with the maximum number of viable cells, it is best to grow 
bacteria only until early stationary phase and then refresh them with 
new medium. 
 
The duration of the phases of the growth curve can be slightly 
different for different conditions of pH, oxygen, salt concentration, 
temperature, nutrients and for different types of bacteria. 
 
 
Figure 3: The typical bacterial growth curve. (http://en.wikipedia.org/wiki/Bacterial_growth) 
 
1.1.2 Escherichia Coli as phage host 
Escherichia Coli (or simply called E. Coli) is a gram negative, rod-
shaped bacterium.  It is a common inhabitant of the lower intestinal 
part of man and warm-blooded animals. Most strains of E. Coli are 
harmless and they are part of the normal microflora of the gut. 
Their principal jobs are the suppression of harmful bacteria and the 
production of vitamins. Nevertheless, some species of E. Coli can 
be responsible of foodborne illness in their hosts.  
 
In this project, a particular strain of E. Coli was adopted as 
bacteriophage host. There are many reasons that can support this 
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choice. Firstly, in the last 60 years E. Coli has been the subject of 
intensive research and now it is the most widely studied prokaryotic 
organism. In particular, it is considered as important host specie in 
Biotechnology and Biology where it is commonly used for the 
manipulation of recombinant DNA. Secondly, this type of bacteria 
can survive outside the body, also at freezing temperatures, so they 
can easily grow in a laboratory environment. Lastly, E. Coli 
represents a powerful model system thanks to its ability to grow in 
chemically prepared media and its high grow rate. Indeed, under 
favourable conditions of temperature, pH, etc., its doubling time is 
roughly 20-30 minutes.  
 
Another important point to highlight is that the bacterial strain 
chosen as phage host is an F- (F minus) mutant. Usually, some E. 
Coli strains can carry an F-plasmid or also called fertility factor, 
because thanks to the production of the sex pilus, the bacterial 
conjugation can take place. It is an episome, in other words a 
plasmid that can integrate itself into bacterial chromosome by 
homologous recombination. There can be only one copy of the F-
plasmid in a given bacterium and bacteria that possess a copy are 
called F-positive or F+ (F plus) while cells that lack F-plasmid are 
called F-negative or F- (F minus) (Figure 4). In order to avoid 
biofilm creation, a mutant F- strain of E. Coli was adopted in this 
work. 
 
 
 
Figure 4: Difference between F-positive (on the left) and F-negative (on the right) cells. 
(http://leavingbio.net/bacteria%20page.htm) 
16 
 
1.2 Bacteriophages 
 
During the 1890s, many bacteriologists had observed something 
that seemed to limit bacterial growth and activity. In particular the 
British Ernest Hanbury Harkin reported the presence of an 
unknown substance with an evident antibacterial activity against 
Cholera disease in the waters of rivers in India (Harkin,1896). But 
the official discover of Bacteriophages occurred only in 1915, when 
the English Frederick Twort observed a growing bacterial culture 
killed by an small agent and hypothesized that it could be a virus. 
The name Bacteriophage was coined by a Canadian biologist called 
Félix d’Hérelle two years later, in 1917, when he discovered “an 
invisible, antagonistic microbe of the dysentery bacillus” 
(d’Herelle, 1917). The meaning of the term “Bacteriophage” is 
“bacteria-eater” from the Greek word “phagein” which means “to 
devour”. So Bacteriophages, also known as phages simply, are 
viruses that can attack and kill bacteria. They are parasites and for 
this reason they need a bacterial host in order to replicate 
themselves. Phages, like bacteria, are easily findable in nature. For 
instance, they can be isolates from sewage, soil and feces.  
 
1.2.1 Morphology of bacteriophages 
 
 
Figure 5: The typical structure of a bacteriophage. (http://en.wikipedia.org/wiki/Bacteriophage) 
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It is possible to find phages with many different sizes and shapes 
but many of them share some common features. Like other viruses, 
bacteriophages are simple organisms which consist of a head, or 
capsid, and a tail (Figure 5). The capsid is composed by one or 
more proteins and its job is to coat and protect the genetic material 
(nucleic acid) that may be either DNA or RNA, double- or single- 
stranded. Most phages have also a tail that is a narrow tube 
indispensable for the viral DNA injection in bacterial hosts. Some 
of more complex phages have one or more tail fibers which ease 
the coupling of the phage to a bacterial cell. 
 
1.2.2 Classification of bacteriophages 
A wide range and variety of phages exists in nature, they can be 
classified in at least 12 different groups considering several factors 
such as viral morphology, genome type, auxiliary structures and 
their host preference. Bacterial viruses are very specific; they may 
infect only one or a limited number of bacteria. Therefore, they are 
usually named according to the bacteria group, strain that they 
infect. For instance, phages that infect the bacterium E. Coli are 
called coliphages. 
 
A second criterion for the classification of bacteriophages is based 
on how they infect host cells and reproduce themselves. Indeed, it 
is possible to distinguish two principal categories of phages 
according to their life cycle: lytic (virulent) or lysogenic 
(temperate).  The main difference between these two types of cycle 
is that during a lytic infection, after the injection of the genetic 
material into the host, phages multiply and kill the cell by lysis in 
order to release new viruses. Conversely, during the lysogenic 
cycle, phages are able to include their DNA or RNA into the cell 
chromosome and replicate it without bursting the host. Only the 
lytic phages are a good choice for developing therapeutic phage 
preparation because lysogenic phages may not destroy bacteria 
immediately and in addition they may transfer virulence genes and 
those mediating antibiotic-resistance to other bacteria (Sandeep, 
2006). 
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1.2.3 T7 Bacteriophages 
 
T7 phages are also called coliphages in so far as they can infect 
most strains of E. Coli. Their genetic material is composed by 
double-stranded DNA and this viral chromosome is coated and 
protected by a protein capsid. In addition to the head, T7 phages 
also possess a tail and some auxiliary structures. Bacteriophage T7 
was discovered in 1945 and as other six members of the group T-
phages, it has a lytic life cycle because it always brings about the 
death of its hosts by lysis after the infection (Figure 6). 
 
 
Figure 6: The lytic cycle of a T7 bacteriophage. (http://textbookofbacteriology.net/phage.html) 
 
 In particular, the first step of the replication is the “adsorption”. 
During this phase, T7 phage recognizes specific receptors on the 
bacterial surface then adheres to those sites using the tail fibers. 
The irreversible binding of the phage to the host is followed by a 
second phase called “penetration” where T7 phage injects its viral 
DNA by means of its hollow tail that work like a syringe while the 
capsid remains outside the cell. Soon after the penetration phase, 
the phage life cycle entries in “eclipse” period. This phase 
represents the interval between the injection of viral genome into E. 
Coli and the release of new phages. The “eclipse” phase is 
dedicated firstly, to the synthesis of a set of early proteins required 
for the replication of the phage DNA; secondly to the production of 
several copies of phage nucleic acid; lastly to the synthesis of late 
proteins which are mainly structural proteins of the capsid and the 
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tail. After the production of all these parts, the assembly phase, 
better known as “maturation”, takes place. Viral genome is 
packaged into the capsid and the tail is linked to it, new mature 
infective phages are accumulated inside the host until a limit, called 
also the burst size. This is the last phase of the phage life cycle, it 
induces the “lysis” of the host and the release of intracellular 
bacteriophages that are able to infect and spread to nearby cells. All 
these phases take about 12-35 minutes to complete, so T7 phage 
has a short life cycle and an excellent ability to expand 
exponentially. Consequently, it is able to defeat pathogenic bacteria 
rapidly. In addition to its fast growth rate, T7 phage has shown a 
high flexibility and adaptivity that suggest it befitting for exploring 
evolutionary principles and for developing new tools to overcome 
the antibiotic resistance issue. (Qimron et al, 2010). 
 
The points listed above are some of the several properties that 
demonstrate the reason why T7 phage was adopted in this project.  
 
1.3 Comparison between bacteriophage therapy 
and antibiotics 
 
Phage therapy and traditional antibiotics have the same goal: defeat 
and kill pathogenic bacteria. Despite that, they have different 
behaviours and working principles, therefore different pros and 
cons. In particular, adopting phages as therapeutic agents, it is 
possible to list several advantages over antibiotics and the mains 
are (Chhibber et al., 2012; Sandeep, 2006): 
 
1) Phages have a very high specificity and thanks to this they 
are not harmful for useful bacteria that live in and on the 
human body. Consequently there are not side effects like 
secondary infections or intestinal disorders that are typical 
cases of many antibiotic treatments.  Furthermore, due to 
their high specificity, it is unlikely to obtain a selection for 
phage resistance in non-target bacteria while using 
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antibiotics with a broad spectrum activity is possible to 
select for resistance of many mutated pathogenic bacteria. 
2) It is very easy to find phages throughout the nature, it is 
estimated that there are about 10
31
 phages on earth and as a 
result of that, viruses are the most abundant life form. Using 
new phages is possible to overcome the issue of phage-
resistant bacteria. Conversely, the development of new 
antibiotic in order to defeat antibiotic-resistant bacteria 
requires many years to accomplish. 
3) Phages have a bactericidal action and usually a single dose 
of them is sufficient to kill pathogens because they are an 
‘intelligent’ drug: they have an exponentially growth and 
they can multiply at the site of infection as long as there are 
bacteria to destroy. Once they have reached the purpose, 
phage too will die because they cannot grow without their 
specific host. Antibiotics can be bactericidal but also 
bacteriostatic, and usually it is necessary to administer 
repeated doses of the drug. 
4) Phage therapy may become a useful alternative for patients 
that are allergic to antibiotics and it can be administered in 
different way in the form of pills, injections, etc. 
 
Considering the features above, it is possible to look at phage 
therapy as a valid alternative approach for the treatment of 
superbugs, bacteria that are resistant to multiple antibiotics, and in 
general of bacterial infections. However it is necessary to overcome 
some problems associated with the use of phages (Chhibber & 
Kumari, 2012; Sandeep, 2006): 
 
1) Their specificity can be a disadvantage when the exact 
species of infecting bacteria is unknown o in presence of a 
multiple infection. Because of this downside, it is necessary 
an identification prior of the pathogenic infection in the 
laboratory. Conversely, one type of antibiotic can defeat 
many different species of bacteria.   
2) Cases of bacteriophage ineffective action were reported, 
maybe because of an incorrect diagnosis or choice of the 
method of phage administration. In particular oral phage 
administration could be neutralized by the gastric acidity; 
phage injected into the bloodstream are recognized by the 
immune system that can produce antibodies against these 
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viruses after a certain period; bacteriophages cannot be used 
against intracellular bacteria because this host is not 
available for the interaction. 
3) Bacteria can also develop resistance to a certain type of 
phages, in this case it is necessary the adoption of new 
species. 
4) A well-defined lytic phage in vitro environment could show 
a different behaviour in vivo and adopt a lysogenic cycle in 
some circumstances. 
 
1.4 Overview of our research 
 
One of the most critical and tricky problem related to the use of 
bacteriophages in order to defeat bacterial pathogens is the fact that 
bacteria can also become resistant to phages. But fortunately, 
phage-resistance is not even remotely as troubling as antibiotic-
resistance. Indeed, one hypothetic solution for this issue is the use 
of new types of phages. When bacteria become resistant to a 
specific kind of phages, they continue to be susceptible to other 
types and it is very easy to find them in the nature that is an endless 
source of phages. But if each newly isolated phage needs approval, 
this process could take a very long time and become too expensive. 
An alternative to the previous solution could be the attempt to 
exploit the phage evolution. In other words, like their bacterial 
hosts and unlike antibiotics, phages are able to mutate, to evolve 
themselves, and then they can fight phage-resistant bacteria 
(Matsuzaki et al., 2005). Furthermore, usually phages can attack 
bacteria by attaching receptors on the bacterial surface that are 
virulence factors, but the development of phage-resistance can 
bring to an alteration of these receptors and consequently make new 
mutants less pathogenic than susceptible bacteria so they can be 
defeated by the human immune system (Inal, 2003).  In addition, it 
is also possible to prevent the evolution and growth of phage-
resistant bacteria, using during the treatments a cocktail of phages 
(a preparation containing different types of phages) and/or in 
combination with antibiotics.  
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The research conducted by the team of Professor Alfonso Jaramillo 
Lab at the School of Life Sciences of the University of Warwick 
forms part of this scenario. The main aim of the work is the 
development of a methodical procedure in order to produce 
engineering synthetic bacteriophage cocktails against specific 
bacteria, forestalling possible phage-resistant mutants. This 
innovative idea is inspired to the principle of the system called 
PACE (phage-assisted continuous evolution) developed in the 
laboratory of Professor David Liu at the University of Harvard. 
Using the PACE platform (Figure 7), it is possible to evolve gene-
encoded molecules that may be associated to protein production in 
E. Coli, continuously without the human intervention and 100 time 
faster than previous traditional methods (Carlson et al., 2014; 
Esvelt et al, 2011). To accomplish this, they have linked the desired 
activity to the production of infectious progeny phage, in particular 
exploiting the expression of protein III (or pIII that is encoded by 
gene III). According Esvelt et al., “phage infection requires protein 
III which mediates F pilus binding and host cell entry. Phage 
lacking pIII are approximately 10
8
-fold less infectious than wild-
type phage”. In order to couple pIII production to the desired 
activity, gene III was deleted from the phage genome and inserted 
into an accessory plasmid (AP) present in E. Coli host cells. These 
cells continuously flow through a fixed-volume called “lagoon” 
containing a replicating population of phages called “selection 
phage” (SP) encoding the gene of interest. Any mutation of host 
cells has a minimal impact on the outcome of the selection over 
many rounds of phage replication because the lagoon dilution rate 
is so fast that only the evolving selection phage population can 
replicate. In this way, only the selection phage with an activity of 
interest can induce the production of a sufficient amount of pIII 
from the accessory plasmid and survive in the lagoon. In theory, it 
is possible to apply PACE system to any gene that can be linked to 
pIII production in E. Coli. There are many activity of interest at 
transcriptional, translational or post-translational levels, for 
instance the evolution of T7 RNAP. This polymerase is very 
specific only for its promoter but using the PACE system the T7 
RNAP was evolved to recognize the T3 promoter and to reject the 
initial sequence target. A second plasmid called “Mutagenesis 
Plasmid” (MP) has been included in the cell hosts. This arabinose-
inducible mutagenesis plasmid promotes the evolution elevating the 
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error rate during DNA replication in particular suppressing 
proofreading and enhancing error-prone lesion bypass. 
 
 
 
Figure 7: Overview of the PACE system. 
(http://www.nature.com/nature/journal/v472/n7344/fig_tab/nature09929_F1.html) 
 
Following a similar principle also the evolution of phages and 
bacteria can take place. Exploiting this idea, it is possible to achieve 
the goal of the research to get phage cocktails. Indeed, it is 
necessary to evolve bacteria and phages, one at time and repeat the 
procedure iteratively. The evolutions can occur using a system such 
as a bioreactor and typical tools of synthetic biology and 
bioengineering.  In this work, a particular strain of E. Coli was 
adopted as phage host: MG1655 ∆fimA-H; ∆flu; 
∆matB::P2_luxCDABE. This is an F minus (F-) strain that 
underwent the deletion of three specific genes in order to avoid the 
formation of biofilm. T7 bacteriophage was adopted as selection 
phage, in particular the T7∆gp5 phage that lacks of the gene 5 in its 
genome. The gene 5 protein (gp5) of bacteriophage T7 is a DNA 
polymerase that is fundamental for the phage replication and 
growth. The deleted gp5 was inserted in an accessory plasmid (AP) 
and included in the F- strain through electroporation process. 
Consequently, the T7∆gp5 phage can reproduce itself only 
attacking the F- that possesses the AP (Figure 8) with gp5.  
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Figure 8: The accessory plasmid pet24_gp5 with Kanamycin resistance. 
 (Courtesy of J. Hassall, University of Warwick) 
 
The host evolution takes place using the original F- strain (without 
AP) and including an arabinose-induced mutagenesis plasmid (MP) 
into it, which increases the probability of mutations.  The cells are 
continuously pumped into the cellstat of a bioreactor in presence of 
a high concentration of phages (MOI>8, see below), in this way 
only the bacteria that develop phage-resistance can survive (Figure 
1.9). New resistant bacteria will be used for the phage evolution 
using the reservoir method and mixing two types of host: one with 
AP and the other with MP (Figure 9). Cycling these two processes, 
it will be possible to get a set of different types of phages that could 
be used as cocktail.  
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Chapter 2:  
2 Phage quantification and 
parameters inference 
2.1 The initial idea of the project 
The traditional method for the phage quantification, also known as 
phage titration, is the plaque assay. This technique is used for the 
detection of the concentration of viruses in a sample. Initially the 
procedure was developed for the titers of bacteriophage stocks, then 
after the modification realized by Renato Dulbecco in 1952, it was 
widely exploited for the quantification of many different viruses as 
well (Dulbecco-Vogt, 1953). It is considered a reliable technique 
easy to implement as its protocol is composed by few simple 
passages (see Chapter 3). The main disadvantage of the procedure 
is the time to wait for the results. Indeed, this method is based on 
the count of the number of plaques, circular zones produced by the 
spread of new infectious viral progeny from infected cells on a Petri 
dish and these can be visible only after a period of incubation that 
lasts usually about 24 hours or at least overnight. The goal of this 
work was the development of an alternative method for phage 
quantification, able to predict the unknown concentration of a 
sample as quickly as possible and avoiding culture techniques with 
Petri plates. The task was accomplished taking advantage of the 
software implementation of a model, that is representative of 
phage-host interactions. In the context of continuous evolution and 
production of synthetic bacteriophage cocktails, this choice was 
also motivated by the need to control, over the time, the 
concentration of free-phages as outcome of the cellstat. In addition 
to the phage quantification, the programs developed for this new 
method have also a second but no less important purpose: the 
inference of unknown model parameters using optimization criteria. 
These parameters reveal some important information concerning 
the characteristics of phages and bacteria. 
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2.2 Models for the bacteriophage-host 
interactions 
The main purpose of the scientific research developed in the field 
of bacteriophage therapy is the possibility of considering the latter, 
in the next future, as a science, a concrete alternative to antibiotics 
in the treatment of pathogens. All this requires a wide knowledge of 
the interactions between bacteriophages and their hosts. Indeed, the 
dynamics that describe the behaviour of phages and cells play an 
important role in the result of the treatment and only the fully 
understanding of these intrinsic dynamical properties will be the 
key to the success. Unfortunately, it is easily comprehensible that 
the quantitative dynamics existing between prey (bacteria) and 
predator (bacteriophage) is too complex and elaborate only for 
human intuition, underlining the need to draw fully on the use of 
mathematical models. It is useful to develop models in order to 
reproduce conditions or theories in a simple way. There are many 
potential advantages and purpose in the use of mathematical models 
of dynamics, from providing a quantitative fitting to empirical data, 
to predicting future unknown outcomes and explaining complicated 
scientific material.   
 
The interactions between bacteriophages and their hosts have been 
investigated for many years (Delbruck, 1940; Krueger & Northrop, 
1930) and some interesting items about their features are still 
subject of scientific debates. Mathematical models, which have 
been proposed for a better understanding of these dynamical 
properties, cover many different area of interest, including 
ecological environment (Levin et al., 1977; Middleboe, 2000), food 
industry (Cattoën, 2003; Mudgal et al., 2006), therapeutic field 
(Cairns et al, 2009; Kasman et al., 2002; Levin & Bull, 1996; Payne 
& Jansen, 2000; Payne et al., 2000) and molecular evolution 
(Husimi, 1989).  Some of them are mainly based on the classical 
Lotka-Volterra equations, known also as the predator-prey 
equations, used to describe the dynamical interaction of two general 
biological species. Only few models describing phage-host 
dynamics have also been validated or analysed mathematically 
(Mudgal et al., 2006). In this work, three different phage-host 
models have been considered and examined. The final best choice 
will be presented after a brief review of their main features and the 
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reasons of selection. It is also important to underline that these 
models are a description of in vitro bacteriophage-host interaction 
so they could not capture the real dynamics which occur in vivo 
environment where some parameters may be critical to treatment 
success. Therefore in the future it will be necessary a better 
understanding of the in vivo system in order to identify a 
relationship between in vivo and in vitro phage-host behaviour 
(Bull & Gill, 2014). 
2.2.1 Model formulations 
The following models have been chosen because they are easy to 
understand and their parameters are highly meaningful and 
purposeful. All state variables are time-dependent, but for the sake 
of simplicity this dependence will be omitted in the equations 
described. 
 
a) In the paper “Understanding bacteriophage therapy as a density-
dependent kinetic process” (Payne & Jansen, 2000), the authors 
present a simple and generic model which describes the variation 
over time of phage and host populations using three differential 
equations:  
𝒅𝒙
𝒅𝒕
= 𝒂𝒙 − 𝒃𝒗𝒙 − 𝑯(𝒕)𝒙 
𝒅𝒚
𝒅𝒕
= 𝒂𝒚 + 𝒃𝒗𝒙 − 𝒌𝒚 − 𝑯(𝒕)𝒚 
𝒅𝒗
𝒅𝒕
 = 𝒌𝑳𝒚 − 𝒃𝒗𝒙 − 𝒎𝒗 − 𝒉(𝒕)𝒗 
• x(t) represents the concentration of uninfected bacteria 
• y(t) the lytic bacteria 
• v(t) the free phage 
• a is the replication coefficient of the bacteria 
• b is the transmission coefficient 
• k is the lysis rate coefficient 
• L is the burst size 
• m is the decay rate of free phage 
• H(t) is the host response against the bacteria 
• h(t) is the host response against the phage 
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The model has been developed exploiting the kinetic properties of 
phage replication and it is able to show as outcome, a range of 
qualitative values for the variables. The work explains paradoxical 
and unpredictable results obtained with the use of bacteriophages in 
the therapeutic field splitting the outcome in different categories 
and considering some critical thresholds. The study illustrates the 
yielding points of bacteriophage biology which can be engineered, 
opening up the path for phage therapy. 
 
b) The second model is described in the following paper: 
“Quantifying the Significance of Phage Attack on Starter Cultures: 
a Mechanistic Model for Population Dynamics of Phage and Their 
Hosts Isolated from Fermenting Sauerkraut” (Mudgal et al., 2006). 
Here the authors concern the possible use of a mechanistic 
mathematical model, in the food industry, in order to quantify the 
growth of phage and host population for different initial conditions. 
The model, validated with two different phage-host systems, is 
composed by 4 delay differential equations: 
 
𝒅𝑺
𝒅𝒕
= 𝜶𝑺 (𝟏 −
𝑺 + 𝑰 + 𝑴
𝑪
) − 𝑲(𝒕)𝑺𝑷 
 
𝒅𝑰
𝒅𝒕
= 𝑲(𝒕)𝑺𝑷 − 𝑯(𝒕 − 𝑳)𝑲(𝒕 − 𝑳)𝑺(𝒕 − 𝑳)𝑷(𝒕 − 𝑳) 
 
𝒅𝑷
𝒅𝒕
= −𝑲(𝒕)𝑺𝑷 + 𝑩𝑯(𝒕 − 𝑳)𝑲(𝒕 − 𝑳)𝑺(𝒕 − 𝑳)𝑷(𝒕 − 𝑳) 
 
𝒅𝑴
𝒅𝒕
= 𝜸𝑴 (𝟏 −
𝑺 + 𝑰 + 𝑴
𝑪
) 
 
• S(t) represents the density of susceptible bacteria  
• I(t) the infected bacteria 
• P(t) the free phage 
• M(t) the resistant bacteria 
• α is the growth rate of susceptible cells 
• γ is the growth rate of resistant cells 
• C the maximum cell density 
• L is the latent period 
• B is the burst size 
• K is the adsorption rate coefficient 
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Considering phage-host kinetic properties, the model includes an 
important delay term (t - L) which represents phage maturation. 
Furthermore, the authors have introduced another change: a step 
function H for a better description of the adsorption rate that varies 
with time. The model results show a systematic difference between 
the parameters obtained from model optimization and those 
acquired from experiments and a possible dependence of some 
parameters on phage or cells densities.  
 
c) The last model considered is described in the paper “Quantitative 
Models of In Vitro Bacteriophage–Host Dynamics and Their 
Application to Phage Therapy" (Cairns et al, 2009). The authors 
focus their attention on the non-linear kinetics of bacteriophage-
host interactions combining experimental and model results. Their 
kinetic model  sharing the assumption of Payne and Jansen (i.e. 
mass-action law), includes a delay term and a variable that 
represents resistant bacteria as in the second paper (Mudgal et al., 
2006): 
 
𝒅𝑺
𝒅𝒕
= 𝒂𝑺 − 𝒇𝑺 − 𝒃𝑺𝑽 
 
𝒅𝑹
𝒅𝒕
= 𝒂𝑹 + 𝒇𝑺 
 
𝒅𝑰
𝒅𝒕
= 𝒃𝑺𝑽 − 𝒃𝑺(𝒕 − 𝑲)𝑽(𝒕 − 𝑲) 
 
𝒅𝑽
𝒅𝒕
= 𝒉𝒃𝑺(𝒕 − 𝑲)𝑽(𝒕 − 𝑲) − 𝒃𝑺𝑽 − 𝒎𝑽 
 
• S(t) represents the concentration of susceptible bacteria (CFU) 
• I(t) the infected bacteria (CFU) 
• V(t) the free phage (PFU) 
• R(t) the resistant bacteria (CFU) 
• a is the growth rate of susceptible and resistant bacteria 
• f is the mutation rate of bacteria 
• b is the binding rate of phages to susceptible bacteria 
• K is the latent period (time between infection and lysis) 
• h is the burst size at lysis 
• m is the phage decay rate due to thermodynamic and other effects.  
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The presence of a delay term (t – K) is fundamental for the 
explanation of a phenomenon: after a period K, the burst of infected 
bacteria releases new phage progeny, in particular about h viruses 
per cell. In this way, at time t it is necessary to consider not only the 
current dynamics but also the concentration of free phage and 
susceptible bacteria at time (t – k). The research represents one of 
the first phage therapy study tested using data acquired on an in 
vitro system and it can be seen as a precursor for the development 
of in vivo phage therapy. 
 
2.2.2 The first data and the final model 
 
The main purposes in the use of a mathematical model are the 
fitting of experimental data and the attempt to give them a meaning 
through the study of the parameter set. An initial fresh cell culture 
(MG1655) with an optical density of 0.14 was divided in different 
tubes and each one was infected by a different concentration of 
phages (T7). The samples were shaken and incubated at 37°C. The 
optical density (OD600) was measured manually every three minutes 
taking 1mL of each sample and using the spectrophotometer. The 
preliminary experimental results of this project are shown below 
(Figure 10). The coloured curves represent the different phage-host 
samples. They show that in a first moment, the concentration of 
bacteria increases following the same trend of the negative control, 
bacteria without the presence of bacteriophages, (black line) but 
after a period, slightly different for each of them, the optical 
densities decrease until zero as consequence of cells death caused 
by phage infection. The curves obtained are similar to the data 
described by Krueger & Northrop in 1930 about “the kinetics of the 
bacterium-bacteriophage reaction”. 
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Figure 10: Optical density measurement over time of the concentration of bacteria infected by 
different dilution of phages. 
The previous models chosen as possible candidates were 
implemented in MATLAB environment in order to try to use them 
for the fitting of these experimental data. The third model (c) has 
shown the best behaviour for our initial problem thanks to its 
flexibility, simplicity and stability. In addition, this mathematical 
model was simplified deleting one differential equation and one 
parameter. This has been possible because this project avoids the 
evolution of susceptible bacteria in resistant mutants (for details, 
see below). Below one will find the correct model adopted with 
R(t)=0 and f=0: 
 
𝒅𝑺
𝒅𝒕
= 𝒂𝑺 − 𝒃𝑺𝑽                                                        (𝟏) 
 
𝒅𝑰
𝒅𝒕
= 𝒃𝑺𝑽 − 𝒃𝑺(𝒕 − 𝑲)𝑽(𝒕 − 𝑲)                         (𝟐) 
 
𝒅𝑽
𝒅𝒕
= 𝒉𝒃𝑺(𝒕 − 𝑲)𝑽(𝒕 − 𝑲) − 𝒃𝑺𝑽 − 𝒎𝑽         (𝟑) 
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There are three state variables S, I, V which represents the 
concentration of susceptible, infected bacteria and free phage 
particles respectively. Five parameters complete the description of 
the model:  
•   a is the growth rate of susceptible bacteria [min
-1
] 
• b is the binding rate of phages to susceptible bacteria              
[CFU
-1
min
-1
] 
•  K is the latent period (time between infection and lysis) [min] 
•  h is the burst size at lysis [PFU] 
• m is the phage decay rate due to thermodynamic and other      
effects [min
-1
]. 
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Chapter 3 
3 Materials and methods 
In this chapter all the materials and methods adopted during the 
project will be illustrated. It is divided in two main sections: the 
first one includes a detailed description of the experimental 
procedures and protocols, while in the latter the programs 
implemented in MATLAB are presented.  
 
3.1 Experimental methods 
 
3.1.1 Enumeration of bacteria 
The number of viable bacteria in a sample is commonly measured 
in colony-forming unit (CFU). A colony represents an aggregate of 
cells derived from a single progenitor cell and becomes visible 
upon a proper incubation time. Their count represents a rough 
estimate of only living cells which are able to replicate themselves 
via binary fission. This is in contrast with the direct microscopic 
counts that include also dead cells. The results can be usually 
reported in CFU/ml or CFU/g for liquid or solid cultures 
respectively. The determination of the number of bacteria in an 
unknown sample is obtained using serial dilutions, plating and 
counting living cells. This method was invented by Robert Koch 
and used for the study of water quality as described in the paper 
“About Detection Methods for Microorganisms in Water” in 1883. 
The first step is the serial dilution (Figure 11), it is necessary 
because usually the concentration of cells in a culture sample 
exceeds the accurate detection range of the assay. It is very 
important to keep in mind the dilution factor adopted in order to 
mathematically compensate for it at the end of the experiment. 
Another relevant point: there is a limit for the number of dilutions 
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that is possible to do. The quantification of bacteria is more 
accurate if the number of colonies counted falls in the range of 30-
300 per Petri dish. Therefore, when the concentration of the starting 
culture is unknown, it is recommended to plate different dilutions 
and have triplicates in order to average the counts together. 
 
The protocol: 
 
 
Figure 11: Serial dilution for the bacterial enumeration. 
(http://2014.igem.org/Team:CSU_Fort_Collins/Notebook/KillSwitch/Sep) 
After the preparation of six small, sterile test tubes labelled from 
10
-1
 to 10
-6
, 0.9 mL of Luria-Bertani (LB) broth were added to each 
one. 0.1 mL of the original liquid culture were inoculated into the 
first test tube and mixed thoroughly using the vortex before 
proceeding. The procedure was repeated for each test tube until the 
last one, withdrawing 0.1 mL of diluted bacterial suspension from 
every last tube and pipetting that into the next one.  0.1 mL of every 
serially diluted specimen that is significant for the counting (30-300 
colonies so usually 10
-4
, 10
-5
, 10
-6
), were plated onto different LBA 
(or LB agar + antibiotic where it was opportune) plates using 
spreaders or glass beads. Minimum three replicates for every 
dilution. After an overnight incubation at 37°C of the plates, upside 
down, the number of colony-forming units (CFU) was counted and 
averaged for each dilution. Finally the concentration of bacteria in 
the original suspension (in CFU/mL) was calculated using the 
following formula: 
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𝑪𝑭𝑼
𝒎𝑳
=
𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒄𝒐𝒍𝒐𝒏𝒊𝒆𝒔 𝒄𝒐𝒖𝒏𝒕𝒆𝒅 𝒊𝒏 𝒕𝒉𝒆 𝒑𝒍𝒂𝒕𝒆
𝑽𝒐𝒍𝒖𝒎𝒆 𝒑𝒍𝒂𝒕𝒆𝒅 (𝒊𝒏 𝒎𝑳) ∗ 𝑻𝒐𝒕𝒂𝒍 𝒅𝒊𝒍𝒖𝒕𝒊𝒐𝒏 𝒇𝒂𝒄𝒕𝒐𝒓
           (𝟒) 
 
For example: if the number of colonies counted in a plate with 0.1 
mL of the sample with dilution 10
-6
 is 60, the CFU/ml is: 
 
CFU
ml
=
60
0.1 ∗ 10−6
= 6 ∗ 108 
 
3.1.2 Enumeration of bacteriophage particles 
The traditional procedure for the measurement of the concentration 
of viruses in a sample is the Plaque Assay. The basic concept is 
similar to the method previously illustrated for the determination of 
CFU/ml. The final results represent only the number of virus 
particles able to form plaques per unit volume and not the total 
quantity of particles. The benchmark is in PFU/mL (plaque-forming 
unit/millilitre). A viral plaque is a circular region generated within a 
solid cell culture by the replication and the spreading of 
bacteriophage viruses and consequently the cell bursts. Usually, the 
final count involves only the plates that contain a number of 
plaques between 10 and 100 in order to minimize the error. 
 
The protocol: 
 
To perform a plaque assay, 10-fold dilutions of a virus stock were 
prepared. 0.1 mL aliquots were inoculated into a tube containing 
3mL of soft agar and 0.3mL of fresh bacteria at an OD value of 0.2 
(or approximately with a CFU of 10
7
). The mix was plated, in 
triplicates, and incubated at 37°C overnight. After the count of the 
number of plaques, the PFU/mL was calculated using the following 
formula: 
 
 
𝑷𝑭𝑼
𝒎𝑳
=
𝑵𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝑷𝒍𝒂𝒒𝒖𝒆𝒔 𝒄𝒐𝒖𝒏𝒕𝒆𝒅 𝒊𝒏 𝒕𝒉𝒂 𝒑𝒍𝒂𝒕𝒆
𝑽𝒐𝒍𝒖𝒎𝒆  𝒑𝒍𝒂𝒕𝒆𝒅 (𝒊𝒏 𝒎𝑳) ∗ 𝑻𝒐𝒕𝒂𝒍 𝒅𝒊𝒍𝒖𝒕𝒊𝒐𝒏 𝒇𝒂𝒄𝒕𝒐𝒓
         (𝟓) 
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3.1.3 Multiplicity of infection 
The multiplicity of infection, or simply MOI, is an important 
parameter to take into consideration in virology since it was 
introduced 70 years ago (Ellis et al., 1939). It is the ratio of 
infectious virions to viable cells in a sample. In other words, the 
MOI is the average number of bacteriophages per bacterium: 
 
𝑴𝑶𝑰 =
(𝑷𝑭𝑼 𝒎𝑳)⁄ ∗ 𝒎𝑳 𝒐𝒇 𝒑𝒉𝒂𝒈𝒆𝒔 𝒂𝒅𝒅𝒆𝒅
(𝑪𝑭𝑼 𝒎𝑳)⁄ ∗ 𝒎𝑳 𝒐𝒇 𝒄𝒆𝒍𝒍𝒔 𝒂𝒅𝒅𝒆𝒅
               (𝟔) 
 
 
This number could be 0.001, 0.01, 0.1, 1, 10, 100, etc., and its value 
can be decided at the beginning of an experiment or deducted in a 
second moment, if the starting concentration of phages or bacteria 
is unknown, using some prediction tools. An essential key point is 
the understanding of the concept of the multiplicity of infection. 
For instance, an MOI of one (e.g. 1000 phages added to 1000 cells) 
does not mean that each cell is infected by one virion. In fact, the 
number of phages that infects each bacterium at different MOI can 
be described by the Poisson distribution: 
 
𝑷(𝒏) =
𝒎𝒏 ∗ 𝒆−𝒎
𝒏!
             (𝟕) 
 
where m is the MOI so the average number of viral agents per 
target, P(n) is the probability to have bacteria infected by exactly n 
phages. In particular:  
 
  𝑷(𝟎) = 𝒆−𝒎 is the probability to get uninfected cells 
 
 𝑷(𝟏) = 𝒎 ∗ 𝒆−𝒎 is the probability to get cells infected by 
one phage 
 
 𝑷(𝒏 > 𝟏) = 𝟏 − [𝑷(𝟎) + 𝑷(𝟏)] = 𝟏 − [𝒆−𝒎 ∗ (𝒎 + 𝟏)] is 
the probability to get cells multiply infected 
 
 𝑷(𝒏 > 𝟎) = 𝟏 − 𝑷(𝟎) = 𝟏 − 𝒆−𝒎 is the probability to get 
infected cells.  
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There is an assumption which underpins this statistical description: 
an equal probability for all cells of a culture to be infected.  
 
Therefore, for a better understanding of the MOI’s interpretation, 
another important concept has to be introduced. When considering 
two samples with the same number of phages and bacteria, then the 
same MOI, but in different volume of medium (e.g. 5mL and 
10mL), even if the final number of infected cells in both cultures 
would be the same, the duration of the adsorption period will sho w 
different (much longer in the bigger volume) (Racaniello, 2014). 
The MOI is easy to calculate and simple to understand but it could 
not be sufficient to describe all the experimental conditions on its 
own (Shabram & Aguilar-Cordova, 2000). Furthermore, it has been 
demonstrated that the use of MOI cannot be appropriate in some 
conditions and an alternative parameter has been proposed 
(Kasman et al, 2002). 
 
In this work, considering what described above, the MOI was used 
in order to keep a record of the concentration of phages and cells in 
the samples and only as a qualitative descriptor of the experimental 
situations. 
 
3.1.4 Phage-host interaction experiment 
The first experiments were conducted using a spectrophotometer. In 
particular, a fresh cell culture with an optical density of 0.1- 0.2 
was equally divided in different tubes, and a different dilution of 
phages was inoculated in each tube. The specimens were incubated 
at 37°C with shaking.  Every 5 minutes, 1mL of each sample was 
withdrawn and its optical density was measured manually. This 
procedure has several disadvantages. Firstly, it is not reliable and 
accurate because of the many delays and imprecisions: no optimal 
growth condition for the culture (they were taken away from the 
incubator every 5 minutes); the need for the operator to fill different 
cuvettes and measure them one at a time; interoperator variability. 
Secondly, there is a waste in terms of time, resources and material. 
Lastly, there is an operative limit for the maximum number of 
samples measurable every 5 minutes. In order to overcome these 
issues, a new automatic procedure was adopted thanks to the use of 
a microplate reader (Figure 12).  This instrument is able of 
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measuring automatically the absorbance over time of several 
samples, controlling the internal temperature and shaking in 
different ways. The cells (MG1655 ∆fimA-H; ∆flu; 
∆matB::P2_luxCDABE, with Kanamycin resistance) and the 
phages (T7∆Gp5) used during these experiments have been 
previously engineered in order to avoid any contamination problem. 
In other words, this type of bacteriophage is able to replicate only 
infecting the cells which possess the Gp5- plasmid. 
 
  
Figure 12: Infinite® F500 Tecan microplate reader 
 
Protocol: 
 
The growth of fresh culture was obtained inoculating cells of an 
overnight culture into a tube with the antibiotic Kanamycin and LB 
medium considering the following proportions: 
 
𝐾𝑎𝑛𝑎𝑚𝑦𝑐𝑖𝑛
𝐿𝐵
=
1
1000
 
 
𝐵𝑎𝑐𝑡𝑒𝑟𝑖𝑎
𝐿𝐵
=
2
100
 
 
the cells were incubated at 37°C and shaken until the achievement 
of an OD600 of 0.2 or better a CFU/ml of about 6*10
7
 (see Chapter 
4). This initial condition value was settled considering two key 
points. Firstly, in 2002, Kasman and his colleagues demonstrated 
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that the common definition of MOI is inadequate for experimental 
conditions in which the cell concentration is minor than 10
7
/mL, 
and as a solution to this issue, they proposed an alternative 
parameter called MOIactual that considers the cell concentration, as 
well as the adsorption time. In order to avoid this problem and 
simplify the picture, the minimum concentration of starting cells 
taken into account is 10
7
/mL. Secondly, the purpose of this work is 
parameter inference and prediction of an unknown bacteriophage 
dilution as soon as possible. The time required to kill all the phage 
hosts, is shorter for a low concentration of cells than for a high one, 
considering a same amount of bacteriophages inoculated 
(MOIhighCONCENTRATION < MOIlowCONCENTRATION). Consequently, this 
represents an upper boundary so that the starting concentration of 
bacteria is approximately 10
7
/mL. It is very important to take a 
record of the starting optical density value because a same amount 
of fresh cells will be used for the prediction of unknown 
concentrations of phages. A sample that comes from the original 
bacteriophage stock was serially diluted from 10
0
 to 10
-10
. The 
standard disposition of bacteria and phages is shown in the figure: 
 
 
 
Figure 13: Standard disposition in 96-well plate. 
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A 96-well plate was used in the experiment for the measurement of 
optical density (Figure 13). Firstly, 0.2 mL of LB medium were 
dispensed in each yellow well; secondly the same amount of each 
different dilution of phages, from 10
0
 to 10
-10
(dilution factor), were 
inoculated into the respective wells; lastly 0.18mL of cell 
suspension was distributed in every green and light blue well. After 
that, using a 12 well multichannel pipette and withdrawing from the 
last line (H) of the plate, a total of 0.02mL of T7∆Gp5 phages with 
different dilution was added to the cell suspension in the light blue 
wells (0.02mL of LB into the green wells) (Figure 14). 
 
 
Figure 14: The use of a multichannel pipette for the dispensation of phages and medium in the 
cells. 
The plate was closed with the lid, previously maintained at 37°C, in 
order to decrease the formation of condensation during the 
experiment, and inserted in the pre-warmed microplate reader. The 
program was settled with a kinetic cycle that consisted in: the 
control of the temperature at 37°C; the shaking of the plate for three 
minutes each cycle; the OD600 measurement of every well except 
the last line sacrificed for the phage dispensation. In particular the 
optical density values were measured in four fixed point of every 
well, three times each, in order to get a better accuracy, so the final 
OD600 is the average of these values. The protocol adopted is a 
modified procedure for the Kinetic Lysis Assays described by 
Qimron and colleagues in the paper “Genomewide screens for 
Escherichia coli genes affecting growth of T7 bacteriophage” in 
2006. 
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3.1.5 Optical density - CFU/mL calibration 
The OD-CFU/mL calibration can be seen as a link between the 
experimental part and the software environment. Indeed, all the 
collected data, which represent the evolution over time of the 
number of cells, are OD values. In order to have a meaningful 
model parameter inference and phage quantification, it is necessary 
to translate these values in CFU/mL. The relationship between OD 
and CFU/mL can be considered linear. 
 
Protocol: 
 
A fresh cells culture was incubated at 37°C and shaken. 4 or 5 
sample were collected from it during the growth and considering an 
OD600 range of 0.1-0.8 (e.g. 0.1 0.2 0.4 0.6 0.8).  Each sample was 
immediately serially diluted and the appropriate dilutions (e.g. 10
-4
, 
10
-5
, 10
-6
) were plated in triplicates and incubated at 37°C 
overnight. After the count of the number of colonies, three 
CFU/mL values were determined for every OD600. The linear fitting 
equation of this relationship was obtained with the use of 
MATLAB. The general equation is: 
 
𝑪𝑭𝑼
𝒎𝒍
= 𝒑𝟏 ∗ 𝑶𝑫𝟔𝟎𝟎 + 𝒑𝟐              (𝟖) 
 
where p1 and p2 are parameters of the straight line and they were 
determined by the best fitting, obtained by the least square method. 
All the optical density values were measured using the 
spectrophotometer. For experimental results derived from the 
TECAN microplate reader, a conversion of ODtecan in 
ODspectrophotometer values has been necessary. In particular, a fresh cell 
culture was incubated at 37°C and shaken, at regular intervals. A 
sample was withdrawn and its optical density was measured using 
both the spectrophotometer and the microplate reader.  
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3.1.6 Definition of delay model parameters 
 
a) Growth Rate 
 
As described in  Chapter 1, the replication process of bacterial 
populations is called binary fission. Bacterial growth is represented 
by the variation of the cell number over time and it follows an 
exponential trend called also doubling. Indeed, during the 
replication, a bacterium can divide into two daughter cells, that are 
genetically identical to the mother cell if no mutation occurs. Thus, 
each bacterial generation is, theoretically, twice the number of the 
previous population but it is important to highlight that no 
necessarily all cells survive.  Considering the first equation of the 
model adopted (1), after a simplification, it represents the first-
order chemical reaction that occurs during the Log-phase of a 
bacteria culture growth, the only one useful for the growth rate 
determination (Hall et al., 2013). 
 
𝒅𝑺
𝒅𝒕
= 𝒂𝑺               (𝟏. 𝒂)    𝒘𝒊𝒕𝒉 𝑽 = 𝟎 (𝒏𝒐 𝒃𝒂𝒄𝒕𝒆𝒓𝒊𝒐𝒑𝒉𝒂𝒈𝒆𝒔) 
 
The equation describes the increment of cell population in time 
(dS/dt) proportional to the number of bacteria present at that time 
and the constant of proportionality a is called growth rate. Its value, 
expressed in h
-1
 or, as in this work, in min
-1
, can be easily 
determined solving the differential equation: 
 
∫
𝒅𝑺
𝑺
𝑺𝒕
𝑺𝒕𝟎
= ∫ 𝒂 𝒅𝒕
𝒕
𝒕𝟎
          (𝟗) 
 
 
 
 
𝐥𝐧 𝑺𝒕 − 𝐥𝐧 𝑺𝒕𝟎 = 𝒂 ∗ (𝒕 − 𝒕𝟎)         (𝟏𝟎) 
 
Thus, the difference between the natural logarithm of the number of 
susceptible cells at time t and the natural logarithm of the number 
of susceptible cells at time t0 is directly proportional to the time 
interval through the constant growth rate a. 
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For a simpler interpretation, the equation can be converted in log10: 
 
𝒍𝒐𝒈𝟏𝟎𝑺𝒕 − 𝒍𝒐𝒈𝟏𝟎𝑺𝒕𝟎 =
𝒂
𝟐. 𝟑𝟎𝟑
∗ (𝒕 − 𝒕𝟎)                 (𝟏𝟏) 
 
Plotting different concentrations of cells (CFUs) present at various 
times and using a log10 scale for the y axis, the result is a straight 
line: 
 
 
 
Figure 15: Log10 of the cell number over time. 
http://colinmayfield.com/biology447/modules/intro/bacterialgrowthrate.htm 
 
The growth rate value represents the slope of the line, namely how 
quickly a particular type of bacterium grows in a particular media. 
It can be calculated making a explicit from the previous equation: 
 
𝒂 =
(𝒍𝒐𝒈𝟏𝟎𝑺𝒕 − 𝒍𝒐𝒈𝟏𝟎𝑺𝒕𝟎) ∗ 𝟐. 𝟑𝟎𝟑
(𝒕 − 𝒕𝟎)
               (𝟏𝟐) 
 
There is a relationship between the growth rate and the doubling 
time or the mean generation time. In particular, the latter is the 
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average time interval required for a population to double and divide 
by binary fission. Considering the equation (5): 
 
 
𝒊𝒇            𝑺𝒕 = 𝟐 ∗ 𝑺𝒕𝟎  
(
𝑡ℎ𝑒 𝑐𝑒𝑙𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑎𝑡 𝑡𝑖𝑚𝑒 𝑡 𝑖𝑠
 𝑡ℎ𝑒 𝑑𝑜𝑢𝑏𝑙𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑐𝑒𝑙𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑎𝑡 𝑡𝑖𝑚𝑒 𝑡0
) 
 
 
𝒕𝒉𝒆𝒏               (𝒕 − 𝒕𝟎) = 𝒅 𝒐𝒓 𝒅𝒐𝒖𝒃𝒍𝒊𝒏𝒈 𝒕𝒊𝒎𝒆 
 
 
𝐥𝐧 𝟐 = 𝒂 ∗ 𝒅 = 𝟎. 𝟔𝟗𝟑        (𝟏𝟑) 
 
 
𝒅 =
𝟎. 𝟔𝟗𝟑
𝒂
               (𝟏𝟒) 
 
Protocol: 
 
Before the advent of microplate readers, the growth rate was 
measured manually. The cultures were grown in a temperature 
controlled environments such as incubators, warm baths, etc. and 
opportunely shaken. At regular intervals of a few minutes, the 
optical density of the samples was measured using the 
spectrophotometer and plotted considering the time in the x axis 
(Hall et al., 2013). With the development of the microtiter plate 
readers the previous procedure can be automatically performed by 
the machine. In this project, considering the phage-host interaction 
experiment previously described (see Paragraph 3.1.4), the useful 
data for the growth rate determination are the mean results of the 
negative controls (only the green wells in Figure 13). It is important 
to underline that the curves used represent only the exponential 
growth of bacteria avoiding the first lag phase. After the conversion 
of the optical density values of these data in CFUs, the parameter 
was automatically calculated by the MATLAB software system 
implemented, using the equation (7). 
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b) Phage Decay Rate 
 
The bacteriophage decay rate m is a constant value which describes 
the number of phage particles lost because of random degradation. 
That can occur due to thermodynamic or other effects (Cairns et al., 
2009). The decay rate is usually expressed in h
-1
 or min
-1
. In order 
to determine the parameter m, a 7-days experiment was conducted 
in absence of a host. 
 
Protocol: 
 
2mL of T7∆Gp5 bacteriophages (PFU/mL=3*10^10) was added to 
18mL of LB rich medium in a 50mL Falcon Tube and hermetically 
closed with Parafilm. They were incubated at 42°C with shaking at 
100rpm for 7 days. At regular intervals, samples were withdrawn 
and serially diluted and inoculated into fresh cell culture (CFU= 
about 10^7) and soft agar for the determination of PFU/mL. Each 
sample was plated in triplicates. The final results were plotted in 
MATLAB environment and fitted considering the solution of a 
simplified equation (3): 
 
 
𝒅𝑽
𝒅𝒕
− 𝒎𝑽           (𝟑. 𝒂)   𝒘𝒊𝒕𝒉 𝑺 = 𝟎 (𝒏𝒐 𝒃𝒂𝒄𝒕𝒆𝒓𝒊𝒂)      
 
 
The solution of this equation is: 
 
∫
𝒅𝑽
𝑽
𝑽𝒕
𝑽𝟎
= − ∫ 𝒎 𝒅𝒕
𝒕
𝟎
          (𝟏𝟓) 
 
 
 
𝐥𝐧 𝑽𝒕 = 𝐥𝐧 𝑽𝟎 − 𝒎 ∗ 𝒕         (𝟏𝟔) 
 
The equation (11) represents a straight line and the value of m was 
obtained as its slope. 
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c) Latent Period 
 
The latent period or incubation period K, is the time interval 
elapsed from the attachment of a phage to the cell wall and the viral 
genome injection until the release of the first new progeny upon the 
burst of bacteria. This parameter is a measure of the duration of the 
lytic phage infection, its replication and assembly, and it is 
expressed in h or min (Adams, 1959). 
 
Protocol: 
 
The latent period was determined using a one-step growth 
experiment. A fresh cell culture (CFU/mL=6*10
7
) was added in a 
100mL conical flask and mixed with bacteriophages considering a 
MOI=0.01 (Cairns et al., 2009; Hyman & Abedon, 2009). The 
entire system is controlled in temperature (at 37°C) and shaken 
using a stir plate (Figure 16a). Samples from the culture were 
withdrawn at periodic intervals and immediately double filtered in 
order to get free phage removing bacteria and bound phages (Figure 
16b). All the specimens were serially diluted and the aliquots were 
plated with fresh bacteria, in triplicates. The determination of this 
parameter value is simple to understand: the number of counted 
plaques,  roughly constant at the beginning, increases progressively 
after the latent period due to the lysis of a bacterial population 
(Delbruck, 1942). 
 
    
Figure 16: a-Latent period experiment on the stir plate. b- Double filtering. 
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d) Burst Size 
 
In the lytic infections, the burst size is the number of new phage 
particles released per infected bacterium. This concept is strictly 
linked to the burst event, in other words, the lysis of the cell. 
Usually the burst size is determined as population averages (called 
also average burst size) (Adams, 1959). In 1980, Gadagkar and 
Gopinathan described in their paper “Bacteriophage burst size 
during multiple infections”, a simple formula for the determination 
of the burst size: 
𝑩𝒖𝒓𝒔𝒕 𝒔𝒊𝒛𝒆 =
𝑬
[𝑩 − (𝑪 − 𝑫)]
          (𝟏𝟕) 
 
Considering (A) as the starting number of bacteria (CFUs) and (B) 
the total number of phages added, the MOI is (A)/(B). At the end of 
the adsorption period, (C) represents the number of infected 
bacteria plus the number of free phages remaining, and (D) the 
number of infected bacteria. Thus, (C-D) is the number of 
unabsorbed free phage. After the latent period, (E) is the number of 
phages released by bacteria lysis. 
 
A similar formula is described in the paper “Lysis Timing and 
Bacteriophage Fitness” (Wang, 2006): 
 
𝑩𝒖𝒓𝒔𝒕 𝒔𝒊𝒛𝒆 =
𝑭
(𝑻 − 𝑼)
                     (𝟏𝟖) 
 
Where T is the starting concentration of total phage: unadsorbed 
phages (free-floating phages) plus infective cells (bacterial cells 
infected with phages); U is the number of unadsorbed phage; F is 
the final concentration of phages after the latent period. 
 
Protocol: 
 
For the determination of the burst size, the previous formulas were 
modified and adapted to this work. The number of plaques was 
counted from the same experiment of the latent period evaluation.  
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e) Binding Rate 
 
The binding rate, or known as adsorption rate, is a measure of the 
combination of bacteriophages with susceptible bacteria, which is 
the first step of phage growth and reproduction. Typically this 
constant considers the portion of irreversible adsorption to cells 
rather than the reversible one. The rate is proportional to the 
number of phages and bacteria (Delbruck, 1940) but it also depends 
on the affinity between them, the bacterial target size, and other 
factors. This rate of phage-host attachment is first order with 
respect to both the concentration of free phage and the 
concentration of bacteria (Krueger, 1930). It can be calculated 
solving the following equation (Ellis & Delbruck, 1938): 
 
𝒅𝑽
𝒅𝒕
= −𝒃𝑺𝑽             (𝟏𝟗)  
 
  
This relationship can be easily obtained from the delay model 
equation (3) considering h=0 and m=0. The experiment for the 
determination of the binding rate value consists of the measurement 
of the free phage decline from time zero, when bacteriophages are 
inoculated into a bacterial culture, to a time immediately before the 
start of bacterial lysis represented by the latent period. Thus, the 
duration of the experiment is minor than the latent period. For these 
reason the previous assumptions can be taken into consideration: no 
lysis so the burst size h=0; the experiment lasts less than one hour 
so the decay rate m=0. The solution of the equation (14) is: 
 
𝑽 = 𝑽𝟎 ∗ 𝒆
−𝒃∗𝑺𝟎∗𝒕           (𝟐𝟎) 
 
Where V and V0 are ending and starting number of phages 
respectively, b is the binding rate constant, t is the established time 
over which the phage adsorption takes place, (Hyman & Abedon, 
2009) and S0 is the concentration of bacteria at time zero. In this 
work, the number of bacteria and bacteriophages are expressed in 
CFU and PFU, the time in minutes, so the binding rate is measured 
in CFU
-1
min
-1
. Considering another way to write the equation (20): 
 
− 𝐥𝐧 (
𝑽
𝑽𝟎
) = 𝑺𝟎 ∗ 𝒃 ∗ 𝒕                 (𝟐𝟏) 
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The latter is similar to the equation of a straight line (Y=m*x), 
where the slope is S0*b. 
 
Protocol: 
 
The number of plaques, which represents the decline of free phage 
over time, was obtained from the same binding experiment of the 
latent period and burst size calculation, considering the results from 
time zero to lysis time (excluded). The data were plotted in 
MATLAB environment and b was obtained by the fitting using the 
equation (16).  
 
 
 
3.2 Software implementation 
All data processing was performed off-line using a commercial 
software package (MATLAB 8.1.0.604, The MathWorks Inc., 
Natick, MA, 2000). The software system implemented is composed 
by five “user-friendly” main programs which are based on different 
secondary functions. In this section, their principal features will be 
briefly described. Furthermore, all the information reported and 
inserted by the user will be specified by the abbreviation UI (User’s 
Information).  
 
 
3.2.1 Plot and summary of the OD measurement 
results 
The main purpose of the MATLAB program A1mainPLOT.m is the 
plot and the summary of the results obtained from the microplate 
reader for the phage-host interaction experiment. The final data, 
recorded usually in a Microsoft Excel file, can be elaborated and 
managed considering the standard protocol adopted for the optical 
density measurement (Figure 17). The first line (white wells) 
represents the blank, usually the medium adopted (e.g. LB); the last 
line (black wells) is not taken into consideration because it was 
“sacrificed” for the phage serial dilution; the first column (green 
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wells) is the negative control (no bacteriophages, only bacteria); the 
remaining coloured columns are different replicates of the same 
sample (0.18mL cells + 0.02mL phages) but each one (or each 
colour) with a different dilution of phages (e.g. the red column 
represents 6 replicates of cells with undiluted phages, the orange 
one with 10
-1
 diluted phages, etc.). It is not necessary to use all the 
wells (e.g. also only three replicates and phage dilutions from 10
-2
 
to 10
-6
) and when the blank value is known, it is possible to use the 
first line for a further replicate. Nevertheless, it is mandatory to 
follow this disposition, filling replicates from up to down and 
dilutions from left to right in descending order. 
 
Figure 17: Standard protocol for the OD600 measurement in a microplate reader. 
 
A1mainPLOT.m description: 
 
The first step is the choice of the excel file, the user can simply 
select it from the right folder. The program considers the blank 
value and shows the plots of the different dilutions of phages, one 
figure for each replicate (UI). After the selection of the only useful 
data (UI) and the time vector to take into consideration, the script is 
able to order automatically the curves with the same dilution of 
phages (also the negative control) and calculate their mean. In order 
to describe the dispersion of the data from the mean curves, the 
program, using the file sigmFITdata.m, can fit the descending part 
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of the curves with a sigmoidal function and calculate the 
coordinates of the midpoint. The dispersion of the midpoints of 
different replicates, for every dilution, is displayed through the 
function herrorbar.m on the plot of the mean curves. The general  
Sigmoidal, or better logistic, equation used by the sigmFITdata.m is 
(in blue): 
 
𝒀(𝒕) =   𝑲 + 𝑨 −   (𝑨 +
𝑲 − 𝑨
𝟏 + (𝒆−
𝒕−𝑴
𝑺 )
)                  (𝟐𝟐) 
 
 
𝒘𝒊𝒕𝒉 𝑨 = 𝟎 
 
Where the four parameters are A, K, M and 1/S. These are the lower 
asymptote, the upper asymptote, the time of the maximum growth 
and growth rate respectively. The lower asymptote equals zero 
because the optical density data to fit are always non negative, thus, 
a negative value for A would be meaningless. Furthermore, the 
equation represents an “inverted" S-shape curve, it was formulated 
considering the generalised logistic function (in red, Figure 18). 
 
Figure 18: Example of a logistic function (red) and an “inverted” logistic function (blue). 
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Parameter values: A=0;  K=1;  M=0;  S=5;
t
Y
 
 
Y1= Logistic equation
Y2= "Inverted" logistic equation
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Analysing the functions: 
 
𝑤ℎ𝑒𝑛             𝑡 → 𝐼𝑛𝑓     𝑡ℎ𝑒𝑛      𝑌1 → 𝐾;    𝑌2 →  0 
                     𝑡 → −𝐼𝑛𝑓                   𝑌1 → 0;    𝑌2 →  𝐾 
      
The midpoints of the data fitting curves are automatically obtained 
thanks to the implementations of a second function “helper” called 
sigmoide.m.  
 
 
3.2.2 Plot and summary of the OD measurement 
results 
The second program implemented in MATLAB environment is 
called A2odCFUcalibration.m. Considering the results of the OD-
CFU/mL calibration experiment, the program is able to return the 
best fit or relationship between these two variables. The conversion 
is of fundamental importance for the phage-host delay model taken 
into account, where the number of susceptible and infected bacteria 
is expressed in CFU and the concentration of phages in PFU. 
 
A2odCFUcalibration.m description: 
 
The first step is the data import: the user can choose the excel file 
with the final results come from the OD-CFU/mL calibration 
(Figure 19).   
 
Figure 19: A template for the OD-CFU/mL calibration results. X=OD; Y=CFU/mL.   
The best fitting of the data can be obtained automatically or 
manually (UI). In the first case, the default MATLAB function used 
is fit.m, and the equation adopted for the fitting is a linear 
polynomial curve with the robust regression method called LAR 
(Least Absolute Residuals). The normal linear least-squares fitting 
has the disadvantage to be sensitive to outliers (extreme values). 
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They have a large influence on the fit because squaring the 
residuals magnifies the effects of these extreme data points. The 
LAR method finds a curve that minimizes the absolute difference 
of the residuals, rather than the squared differences. Therefore, 
extreme values have a lesser influence on the fit. With the second 
option, the user has the possibility to choose the best function and 
options for the fitting using the Matlab toolbox cftool and save the 
results in the workspace (Figure 20a). Nevertheless, a first-order 
fitting function is recommended. The last passage of the program 
consists of the CFU/ml determination for the initial amount of cells, 
in other words, the concentration of bacteria at the beginning of the 
microplate reader experiment. The user can manually select its 
value if it is known, otherwise inserting the starting OD value, the 
program can automatically calculate the CFU/mL with the use of 
the fitting relationship or graphically through the ginput.m 
command (UI) (Figure 20b).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: a-Matlab Curve Fitting application. b-Matlab Ginput command. 
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3.2.3 First fitting attempt and parameter 
research 
The program A3mainFIT.m represents the third passage of the 
software system implemented. It depends on the information about 
the mean curves of the phage-host interaction and the calibration of 
optical density and CFU/mL, collected from A1mainPLOT.m and 
A2odCFUcalibration.m respectively. Its main aim is the research of 
the optimal values for the five model parameters, which give the 
best fitting with the data. This optimization research is 
accomplished for each sample (or mean curve), obtaining in this 
way, a series of parameter sets equal to the number of curves taken 
into account. The procedure leads to a situation called “overfitting”, 
but the results are only partial: they represent the starting point for 
the research and optimization of a final parameter set values, 
described in the next section. The main reason why it is preferable, 
firstly, optimize different parameter sets for every single sample 
rather than one set for all the samples, is the saving in terms of time 
and computational complexity. Indeed, the research of parameter 
values requires the minimization of an error function, and the 
solution of the differential delay equations, which represents the 
best fitting between data and model, might be only a local 
minimum. In order to overcome this issue, a global minimum 
research is adopted, considering different initial value for the 
parameter set. The idea of this software system is to conduct the 
global research for each sample, one at time, so as to limit the range 
of the possible values, and at a later stage, to obtain the ultimate 
parameters. 
 
 
A3mainFIT.m description: 
 
After the loading of the data coming from the execution of the 
previous programs, the user can insert the PFU/mL values for the 
current bacteriophages, considering this value for the highest 
concentration adopted during the experiment (e.g. if the first 
dilution is 10
-1
 then the PFU/mL is 3*10
9
; if the first dilution is 10
-2
 
then the PFU/mL is 3*10
8
).  The second step is the growth rate 
calculation. This value can be obtained using the formula 
previously illustrated (Equation 12) and applying it to the negative 
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control (no bacteriophages) mean curve. In particular the two points 
necessary for the calculation can be detected automatically as the 
initial and the end points of the experiment, or manually with the 
use of ginput.m. After the automatic definition of the initial 
conditions for bacteria and bacteriophages, the global minimum 
research takes place in a structured “for” cycle. It requires the use 
of different user-defined and standard MATLAB functions. Firstly, 
the model delay differential equations are implemented in the 
function cairns.m, this is recalled by an helper function helper.m 
which is able to solve the system using the built-in MATLAB 
solver dde23.m, specialized in the resolution of delay differential 
equations with constant delays. Secondly, the function lsqcurvefit.m 
allows the research of the best fitting between data and model. It is 
able to solve the nonlinear curve-fitting problems in least-squares 
sense. In other words, considering xdata as the starting values (the 
initial guess) of the parameter set, and ydata as the observed data, it 
finds the coefficients x that solve the problem: 
 
𝐦𝐢𝐧
𝒙
‖𝑭(𝒙, 𝒙𝒅𝒂𝒕𝒂) − 𝒚𝒅𝒂𝒕𝒂‖𝟐
𝟐
= 𝐦𝐢𝐧
𝒙
∑(𝑭(𝒙, 𝒙𝒅𝒂𝒕𝒂𝒊) − 𝒚𝒅𝒂𝒕𝒂𝒊)
𝟐              (𝟐𝟑)
𝒊
 
 
Where the research of x values is limited by a lower and an upper 
bounds, LB and UB respectively. In particular, the LB and UB for 
the growth rate are established considering its experimental value 
(Bound𝑔𝑟𝑜𝑤𝑡ℎ𝑅 = 𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙𝑔𝑟𝑜𝑤𝑡ℎ𝑅 ±
𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙𝑔𝑟𝑜𝑤𝑡ℎ𝑅
5
) 
while the bounds for the other parameters are fixed in a meaningful 
range. Lastly, in order to obtain the global minimum value, 
avoiding local minimum points, the research has to be extended to 
the entire range between LB and UB. This is possible thanks to the 
adoption of the MultiStart.m and the creation of a minimum 
optimization problem with helper.m as the objective of 
lsqcurvefit.m. The different starting points, which represent the 
initial parameter sets, are created using ndgrid.m and considering 
all the possible combinations of defined values between LB and 
UB. For example, considering LB= [0.0137 0 0 0 0.0001]   and   
UB= [0.0205 1e-9 500 30 0.1], the bounds for growth rate, binding 
rate, burst size, latent period and decay rate respectively, and 
comNUMpar=[3 4 3 4 1], the vector representing the number of 
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values between LB and UB taken into account as starting points 
(e.g. growth rate=[0,0137 0,0171 0,0205], binding rate=[0 3.3e-10 
6.7e-10 1.0e-9], etc.), ngrid.m returns all the possible combinations 
of these values: 
     
0,0137 0 0 0 0,10 
0,0171 0 0 0 0,10 
0,0205 0 0 0 0,10 
0,0137 3.33E+04 0 0 0,10 
0,0171 3.33E+04 0 0 0,10 
0,0205 3.33E+04 0 0 0,10 
0,0137 6.67E+04 0 0 0,10 
0,0171 6.67E+04 0 0 0,10 
0,0205 6.67E+04 0 0 0,10 
0,0137 1.00E+05 0 0 0,10 
0,0171 1.00E+05 0 0 0,10 
    … 
 
In order to avoid the model instability issue for some range of 
starting values, through the ddeset.m, it is possible to create a DDE 
(delay differential equation) option structure, in particular an 
“Event Location Property” called MyEventFunction.m. If the solver 
detects such event during the solution of a problem (i.e. the run 
time exceeds three seconds), the function will terminate the 
execution of the dde23.m solver.  Summarizing: 
 
For each mean curve 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
End. 
Run the MultiStart 
objective 
Use ngrid for 
the creation of 
starting points 
With the 
lsqcurvefit 
problem 
Adopt the 
helper as 
objective 
Use the dde23 solver 
with 
MyEventFunction 
Solve the cairns delay 
system 
Plot and save the best 
fitting parameter values 
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3.2.4 Final parameter optimization. 
The main purpose of the program A4mainCROSS.m is the 
identification of the best parameter set, valid for all the previous 
samples. It considers the results of different sets obtained by the 
execution of A3mainfit.m, as starting point. The model parameter 
optimization is possible by means of the Cross Validation method. 
The Cross Validation (or abbreviated CV) is a statistical method for 
the evaluation of accuracy and validity of a model (Refaeilzadeh, 
2009). Indeed, in statistics, a typical goal is to learn a model from 
the available data. Consequently, evaluating the prediction 
capability of the model on the training data adopted, the model 
might show a good behaviour, but this is not an indication of its 
predicting performance for the future unseen data. The idea of CV, 
originated in the 1930s (Larson, 1931), is the estimation of the 
generalization performance and the model selection. In particular, 
the available dataset is divided into two segments: one used to learn 
a model (training set) and the other adopted to validate the model 
(validation or testing set). There are different types of CV, the main 
ones are: 
 
a) The holdout method  
It represents the simplest CV procedure. The dataset is 
globally divided into only 2 non-overlapped sets. The model 
fitting is performed considering the training set and the 
function approximator so obtained has the goal to predict the 
remaining unseen data of the testing set. The method has the 
advantage to be better than the normal residual evaluations, 
because of the presence of the testing set, and to be not 
computationally complex. The downside is the high variance 
of its evaluation, which depends heavily on how the 
available dataset is divided into the two different sets. 
 
Figure 21: The hold-out data split. (http://scott.fortmann-roe.com/docs/MeasuringError.html) 
b) K-fold cross validation 
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This method represents the next development of the previous 
one. At the first, the dataset is partitioned into k equal (or 
nearly equal) subsets or folds. The process considers one of 
the k subset as validation set and the other k-1 subsets as 
training set (Figure 21). This procedure is iteratively 
repeated k times and at each iteration, a different fold of the 
data is considered. In this way, every sample gets to be in a 
testing set once and in a training set k-1 times. With the 
increase of k value, the method shows a lower variance, but 
at the expense of the execution time and the computational 
complexity.
 
Figure 22: K-fold Cross Validation with k=3 and dataset of 30 elements. 
(http://homepages.inf.ed.ac.uk/pmartin/tutorial/case_studies.html) 
 
c) Leave-one-out cross validation 
This method, also abbreviated as LOOCV, is a special case 
of the K-fold CV with k equals to the number of data points 
N. Thus, during the N iterations, each time only one point is 
used for the testing while the remaining N-1 data are 
considered for the determination of the function 
approximator. The LOOCV presents a very accurate 
performance estimation but also a higher computational cost. 
It is widely used when only a small number of data is 
available. 
 
 
Figure 23: The leave one out split. Every fold represents only one sample and k=number of 
samples. (https://www.packtpub.com/books/content/learning-how-classify-real-world-examples) 
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The CV method can be applied in three main contexts: firstly, for 
the performance estimation of the learner model from available 
data using one algorithm, in other words, to quantify the 
generalizability of an algorithm; secondly, for the model selection, 
the comparison of the behaviour of different algorithms considering 
the available data; lastly, for the tuning of the model parameters, 
considering the performance of two or more variants of a 
parameterized model and trying to achieve the best results with the 
dataset taken into account (Refaeilzadeh, 2009). The third and last 
case represents the main purpose of this work, as described at the 
beginning of this section. The available dataset considered is 
composed by the averaged curves of different replicates, they are 
not simple points but they represent the evolution of cell population 
in time, as a consequence of the interaction with infecting 
bacteriophages. The leave-one-out cross validation method was 
adopted, considering the small number of the experimental data 
used. 
 
A4mainCROSS.m description: 
 
After the loading of the data coming from the previous software 
programs, the execution of A4mainCROSS.m is mainly based on the 
for cycle that represents the implementation of the LOOOCV 
method. In particular, during each iteration, one mean curve is held-
out for validation (test) while the remaining ones are used for 
learning (training). The procedure repeated cyclically adopts, as 
starting parameters, the median values of the parameter sets, 
obtained in A3mainFIT.m, but only those attributed to the training 
set. Using lsqcurvefit.m and helper4.m, it is able to find the best 
fitting parameter values for the training set taken into consideration 
and to test this set on the validation mean curve. The following 
error is recorded each time: 
 
𝑬𝒓𝒓𝒐𝒓𝒌 = ∑(𝒀𝒎𝒐𝒅𝒆𝒍 𝒌−𝟏 − ?̂?𝒆𝒙𝒑𝒆𝒓𝒊𝒎𝒆𝒏𝒕)
𝟐
               (𝟐𝟒) 
 
  
In other words, the error for the kth sample is represented by the 
sum of the squared difference between the fitting curve using the 
best parameter set obtained for the training set k-1 and the 
experimental data of the kth mean curve. At the end of the 
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execution of all the iterations, there are k parameter sets, with k 
equals to the number of available samples, but only the one with the 
minimum error accumulated, represents the final optimized 
parameters. The latter was adopted for the final fitting and plotting 
of all the data. Summarizing the iterative process: 
 
 
For each mean curve k (with k=N, the number of samples) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
End 
 
 
 
 
 
 
Starting parameters= median ( parameter set 1…N except K) 
                                                   
 
Best parameter fit for the training 
set (1…N except K)  
using lsqcurvefit and helper4 
Validation of the training set 
parameters on the testing set K 
Calculation of the error for the 
testing set K 
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3.2.5 Model prediction 
 
The last program implemented A5mainPREDICTION.m has the 
purpose to collect the data elaborated by the previous scripts and to 
use them for the model prediction. This is realizable thanks to the 
conversion of the new data, expressed in optical densities, in 
CFU/mL and the normalization of them, as well as of the previous 
model “training” dataset, to their respective starting OD values. 
Indeed, one of the two main aims of this project is the prediction of 
one or more unknown concentrations of bacteriophages. In order to 
get new curves over time that are comparable to the model training 
dataset, it is important to follow the same procedure adopted 
previously, thence the use of a microplate reader, the measurement 
of the OD600 every five minutes, etc., in other words, to recreate the 
same experimental condition. In addition, considering the model, it 
is necessary to maintain the same starting bacterial concentration of 
the previous experiment and to infect it with an unknown dilution 
of phages of interest. Only in this way it is possible to obtain a 
curve over time that describes the variation of the cell population in 
CFUs and to make predictions. One of the issues of this procedure 
is the presence of variability in the starting OD values of different 
experiments. It is highly unlikely the adoption of the same 
concentration of bacteria every time. Thus, the normalization of the 
data is a way to “synchronise” them, in order to get a better 
comparison. 
 
The correlation coefficient is adopted as criterion of comparison 
between model and unknown curves. In general, the correlation 
quantifies the extent to which two variables, X and Y, vary in 
related way. The relationship between them can be easily found 
considering the scatter plot of the data (Figure 24). A positive 
correlation exists when high values of X are associated with high 
values of Y. Conversely, a negative correlation exists when high 
values of X are associated with low values of Y. There is no 
correlation if the values of X are not at all predictive of values of Y. 
The degree of the correlation is quantified by the correlation 
coefficient R, which is a unit-free term. The value of R always lies 
between -1 and +1. The calculated R assumes a positive value when 
the slope on the graph rises from left to right and a negative value 
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when the slope rises from right to left. Ideally, R=+1 or R=-1 if all 
the points of a scatter plot fall on a line with upward or downward 
incline respectively. Such perfect correlation is seldom encountered 
(e.g. when the two variables compared are identical Y=X). 
However, the correlation coefficient defines the correlational 
strength, and strong correlations are associated with scatter clouds 
that adhere to the imaginary trend line. Therefore, the closer R 
value is to +1, the stronger the positive correlation. The closer R is 
to -1, the stronger the negative correlation. 
 
 
 
Figure 24: Scatter plot of the variables X and Y. (http://math.tutorvista.com/statistics/correlation-
and-regression.html) 
The common formula for the measure of the linear correlation 
between X and Y is called Pearson product-moment correlation 
coefficient and it is defined as: 
 
𝑹 =
𝑺𝑺𝑿𝒀
√𝑺𝑺𝑿𝑿 ∗ 𝑺𝑺𝒀𝒀
                         (𝟐𝟓) 
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It requires the calculation of three different sums of squares (SS): 
 
 
-the sum of squares for variable X 
 
𝑺𝑺𝑿𝑿 = ∑(𝒙𝒊 − ?̅?)
𝟐                       (𝟐𝟔) 
 
 
-the sum of squares for variable Y 
 
𝑺𝑺𝒀𝒀 = ∑(𝒚𝒊 − ?̅?)
𝟐                         (𝟐𝟕) 
 
 
-the sum of their cross-products 
 
𝑺𝑺𝑿𝒀 = ∑(𝒙𝒊 − ?̅?) ∗ (𝒚𝒊 − ?̅?)         (𝟐𝟖) 
 
In this work, the linear correlation is considered as the yardstick for 
the sample but it is important to underline that a value of R close to 
0 means that there is not a linear correlation and not necessary that 
there is not a relationship between them. 
 
Another significant variable to take into consideration is the p-
value. This is a method, adopted in statistics, which gauges the 
“significance” of the accomplished analyses. In this case, it is 
possible to consider the no correlation between the variables X and 
Y as null hypothesis and their correlation as the alternative 
hypothesis. The p-value is a number that lies in the interval [0,1] 
and it can be interpreted in the follow way: 
- A small  p-value (usually ≤ 0.05) suggests that the observed 
data are inconsistent with the assumption that the null 
hypothesis (no correlation) is true, and thus that hypothesis 
must be rejected and the alternative hypothesis (X and Y are 
correlated)  is accepted as true; 
- A large p-value (usually > 0.05) indicates weak evidence 
against the null hypothesis, so the null hypothesis cannot be 
rejected. 
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A5mainPREDICTION.m description: 
 
After the loading of the data previously elaborated, the user can 
select the excel file containing the new data to predict. Both the 
mean curves and the unknown samples are normalized. A second 
step of elaboration consists of the cutting or the interpolation of the 
new data, depending on their size, and the OD conversion in 
CFU/mL, in order to have all the data with the same length, then 
comparable. Using the MATLAB function corrcoef.m, the 
correlation coefficient and the p-value are calculated, as result of 
the comparison between each single new sample and each mean 
curve.  An unknown sample is more similar to the mean curve that 
returns the highest value for R and with a p-value <0.05. In 
particular, a strong correlation is present when |R|>0.75, and a 
moderate correlation when 0.75>|R|>0.67. In addition, if the |Rmax|-
|Rsecond|≤0.03, where Rmax is the maximum R value and Rsecond the 
coefficient that represents the correlation between the unknown 
sample and a second mean curve, then the prediction is between 
two results. Knowing the starting concentration of bacteria, the 
final outcome of the program is the prediction of the starting 
unknown concentration of phages for all the new data. 
Summarizing the  for cycle for the comparison:  
 
For each new data 
 
 
 
 
 
 
 
 
 
 
End 
 
 
 
 
 
 
Normalization 
 
First elaboration (OD-CFU/mL conversion…) 
Comparison with the mean curves using corrcoef and 
calculation of R and p-value 
 
 
66 
 
Chapter 4 
4 Results and Discussion 
4.1 CFU/mL 
 
The CFU/mL value for the MG1655 ∆fimA-H; ∆flu; 
∆matB::P2_luxCDABE bacterial strain was calculated considering 
an ODspectrophotometer of about 0.2. For the bacterial enumeration, two 
experiments were conducted in different days and for each one, the 
specimens were plated in three replicates. The final value 
represents the average result of the count of colonies (figure 25). 
 
 
Figure 25: Bacterial colonies after an overnight incubation at 37°C. 
 
CFU/mL Replicate1  Replicate2 Replicate3 
Experiment 1 61*10E+6 62*10E+6 57*10E+6 
Experiment 2 64*10E+6 63*10E+6 55*10E+6 
 
 
 
𝒇𝒓𝒐𝒎 𝒕𝒉𝒆 𝒆𝒒𝒖𝒂𝒕𝒊𝒐𝒏 (𝟒)           
𝑪𝑭𝑼
𝒎𝑳
= 𝟔 ∗ 𝟏𝟎𝟕    
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4.2 PFU/mL 
 
Figure 26: Viral Plaques after an overnight incubation at 37°C. Plaques are circular and clear 
zones formed in a lawn of cells due to lysis by phage. 
The PFU/mL value for the T7∆gp5 bacteriophages was calculated 
considering the Plaque Assay result. Following the Plaque Assay 
protocol, 0.1mL of phages were inoculated in 0.3mL of bacteria 
with a ODspectrophotometer of about 0.2 (CFU=0.3* 6*10
7
=1.8*10
7
). 
After an overnight incubation at 37°C, the number of plaques 
(Figure 26) was counted from each one of the three replicates 
plated and averaged, obtaining in this way the final value: 
 
PFU/mL Replicate 1 Replicate 2 Replicate 3 
Plaque Assay-OD=0.2 30*10E+9 35*10E+9 32*10E+9 
  
 
 
 
𝒇𝒓𝒐𝒎 𝒕𝒉𝒆 𝒆𝒒𝒖𝒂𝒕𝒊𝒐𝒏 (𝟓)             
𝑷𝑭𝑼
𝒎𝑳
= 𝟑 ∗ 𝟏𝟎𝟏𝟎 
 
In order to see which could be the dependence of the PFU/mL 
value on the concentration of cells used, a second Plaque Assay 
experiment was accomplished considering a starting 
ODspectrophotometer of about 0.8 (CFU/mL>>6*10
7
)  and no significant 
differences were founded: 
 
PFU/mL Replicate 1 Replicate 2 Replicate 3 
Plaque Assay-OD=0.8 35*10E+9 36*10E+9 40*10E+9 
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4.3 MOI 
As previously described (section 3.1.3) the number of phages that 
infects each bacterium at different MOI can be described by the 
Poisson distribution. Considering the probability to get infected 
cells: 
𝑃(𝑛 > 0) = 1 − 𝑃(0) = 1 − 𝑒−𝑚 
 
As the MOI increases, the percentages of cells infected with at least 
one viral particle also increases: 
 
MOI  % Infected 
0.01 0.10% 
0.1 9.50% 
1 63.20% 
2 86.50% 
3 95.00% 
4 98.20% 
5 99.30% 
6 99.80% 
7 99.90% 
8 ~100.0% 
 
Figure 27: Percentage of infected cells at different MOI. 
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Considering the CFU/mL, PFU/mL and the phage-host interaction 
protocol (section 3.1.4), which consists of the addition of 0.02mL 
of phages and 0.18mL of bacteria in each well, the MOI was 
calculated as: 
 
𝒇𝒓𝒐𝒎 𝒕𝒉𝒆 𝒆𝒒𝒖𝒂𝒕𝒊𝒐𝒏 (𝟔)       𝑴𝑶𝑰 =
𝟑 ∗ 𝟏𝟎𝟏𝟎 ∗ 𝟎. 𝟎𝟐
𝟔 ∗ 𝟏𝟎𝟕 ∗ 𝟎. 𝟏𝟖
≈ 𝟔𝟎 
 
 
This MOI value is valid for the undiluted concentration of phages. 
Consequently, considering the concentration of cells constant, for 
each serial diluted sample, the MOI would be: 
 
Dilution MOI 
10^0 -undiluted 60 
10^-1 6 
10^-2 0.6 
10^-3 0.06 
10^-4 0.006 
10^-5 0.0006 
10^-6 0.00006 
… … 
 
It is strictly necessary maintaining the same starting OD or CFUs 
both for the “training” dataset and for the future unknown sample. 
Only in this way the prediction of the concentration of 
bacteriophages is possible. Indeed, the curves obtained by the 
evolution over time of different sample with a same dilution of 
phages but different starting OD, are different, so the prediction 
could not be reliable (Figure 28). Another observation is that there 
is also a difference between achieving the correct starting OD 
directly and obtaining it upon dilution of the bacterial culture. For 
instance, if the starting OD chosen is 0.2, then growing a fresh 
culture from a very low concentration until 0.2 is different from 
reaching this value diluting a culture at an OD of 0.7 with LB 
medium. In particular, the result of the second method is the 
presence of a delay for the curves (Figure 29), whose entity 
increase with the dilution factor.. Thus, only the first growth 
method was adopted. 
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Figure 28: Curves with the same phage dilution (the same colour) but with different starting 
concentration of cells. X=time; Y=OD. 
 
 
 
Figure 29: Curves after normalization, every colour represents a different dilution of phage. Solid 
lines: starting OD (0.2) value achieved directly from the growth of a low bacterial concentration 
(0.04). Dotted lines: starting OD (0.2) value achieved diluting a high bacterial concentration (0.7). 
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4.4 A1mainPLOT.M  
The A1mainPLOT.m program plots, at first, the general results 
coming from the microplate reader experiment, generating a figure 
for each replicate (Figure 30). Once the user has selected the data of 
interest and the cutting time (Figure 31), the program is able to 
elaborate and summarize them considering the average and the 
standard deviation of their values in time (Figure32). 
 
 
Figure 30: The plot over time of a single replicate with all its samples. 
 
Figure 31: The command window of A1mainPLOT.m. 
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Figure 32: The summary of the data in mean curves. Each black line represents the standard 
deviation of the respective curve. 
 
 
4.5 A2odCFUcalibration.m 
The experimental results of the OD-CFU/ml calibration are 
summarized in the following table: 
 
OD-CFU/mL 
calibration Replicate 1 Replicate 2 Replicate 3 
OD: 0 0 0 0 
OD: 0.150 5.20E+07 6.50E+07 5.00E+07 
OD: 0.214 6.30E+07 6.40E+07 5.50E+07 
OD: 0.329 7.30E+07 6.60E+07 7.50E+07 
OD: 0.495 1.64E+08 1.47E+08 1.46E+08 
OD: 0.700 3.80E+08 5.00E+08 4.20E+08 
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Where the number of colonies was counted from each replicate 
after an overnight incubation at 37°C and consequently, the 
CFU/mL was calculated taken into account the dilution factor. The 
linear model that represents the best fitting of the data was 
automatically calculated by A2odCFUcalibration.m (Figure 33) and 
plotted (Figure34). 
 
 
Figure 33: OD-CFU/mL calibration results. 
 
 
 
Figure 34: The plot of the linear fitting equation. 
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Considering the presence of a bias between ODspectrophotometer and 
ODtecan, an additional experiment was performed in order to obtain 
a conversion value:  
 
OD spectr OD tecan ODspectr/ODtecan 
0.15 0.051 2.94 
0.214 0.056 3.82 
0.329 0.101 3.25 
0.495 0.143 3.46 
0.7 0.197 3.55 
 
 
𝑶𝑫𝒔𝒑𝒆𝒄𝒕𝒓𝒐𝒑𝒉𝒐𝒕𝒐𝒎𝒆𝒕𝒆𝒓 ≈ 𝟑. 𝟒 ∗ 𝑶𝑫𝒕𝒆𝒄𝒂𝒏 
 
 
 
4.6 A3mainFIT.m and A4mainCROSS.m 
The results of the A3mainFIT.m program are shown below: 
 
Curve  
(PFU/mL) 
Growth 
Rate 
 [min-1] 
Binding 
 Rate  
[CFU-1min-1] 
Burst 
size 
[PFU] 
Latent 
period 
[min] 
Decay 
Rate 
[min-1] 
3*10^8 0.0175 1.81E-10 433 9 0.0091 
3*10^7 0.022 1.78E-10 483 8 0.0088 
3^10^6 0.022 1.96E-10 520 10 0.0091 
3*10^5 0.213 1.45E-10 520 8 0.0077 
3*10^4 0.0224 2.05E-10 520 10 0.0089 
 
In particular, the global minimum research, performed for each 
sample, requires an execution time in the order of hours. This 
computational period is strictly depending on the number of data 
considered, the bounds and the starting points adopted. The 
parameter optimization was accomplished using the Leave-One-
Out Cross Validation method and the final values for the parameter 
set are: 
Final 
Parameter 
set 
Growth 
Rate 
 [min-1] 
Binding 
 Rate  
[CFU-1min-1] 
Burst 
size 
[PFU] 
Latent 
period 
[min] 
Decay 
Rate 
[min-1] 
  0.0213 1.75E-10 500 9 0.0089 
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Afterwards, the optimized values were adopted in order to solve the 
delay differential equations of the model and to obtain the ultimate 
curve fitting (Figure 35). 
 
 
Figure 35: The curve fitting with the optimized parameter set. 
 
 
 
A.7 Experimental parameters 
a) Growth Rate 
 
The growth rate value is automatically calculated by the program 
A3mainFIT.m using the mean curve of the negative controls (Figure 
36): 
 
𝑬𝒙𝒑𝒆𝒓𝒊𝒎𝒆𝒏𝒕𝒂𝒍 𝑮𝒓𝒐𝒘𝒕𝒉 𝑹𝒂𝒕𝒆 = 𝟎. 𝟎𝟐𝟏𝟗 [𝒎𝒊𝒏−𝟏] 
 
 
𝑬𝒙𝒑𝒆𝒓𝒊𝒎𝒆𝒏𝒕𝒂𝒍 𝑫𝒐𝒖𝒃𝒍𝒊𝒏𝒈 𝑻𝒊𝒎𝒆 =
𝟎. 𝟔𝟗𝟑
𝟎. 𝟎𝟐𝟏𝟗
≈ 𝟑𝟐 [𝒎𝒊𝒏] 
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Figure 36: Experimental growth rate. 
 
b) Latent Period 
 
The one-step growth experiment results are shown in the following 
table: 
 
One-step growth 
experiment  
(Number of plaques 
*104) 
Replicate 
1 
Replicate 
2 
Replicate 
3 
0- min 50 60 40 
0+ min 36 34 31 
2 min 28 34 31 
4 min 36 30 31 
6 min 33 30 30 
8 min 27 26 24 
10 min 21 23 27 
11 min 25 18 16 
12 min 28 24 20 
14 min 600 460 390 
16 min 560 520 440 
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Figure 37: One-step growth for the Latent Period determination. 
From the plot of these values in Log10 (PFU) (Figure 37), it is 
possible to observe a remarkable increase in the number of plaques 
after about 12 minutes. The experiment was repeated in different 
days in order to get a better accuracy and it showed the same result 
every time. Thus, the latent period is: 
 
𝑬𝒙𝒑𝒆𝒓𝒊𝒎𝒆𝒏𝒕𝒂𝒍 𝑳𝒂𝒕𝒆𝒏𝒕 𝑷𝒆𝒓𝒊𝒐𝒅 ≈ 𝟏𝟐 [𝒎𝒊𝒏] 
 
 
c) Binding Rate 
 
Considering the equation (21) and the one-step growth result until 
10 minutes (before the lysis of bacteria), the curve that fits the data 
is a straight line (Figure 38) whose slope is S0*b, with S0 the 
starting number of susceptible bacteria. Hence, the binding rate b is 
(slope/S0): 
 
𝑬𝒙𝒑𝒆𝒓𝒊𝒎𝒆𝒏𝒕𝒂𝒍 𝑩𝒊𝒏𝒅𝒊𝒏𝒈 𝑹𝒂𝒕𝒆 = 𝟏. 𝟗𝟐 ∗ 𝟏𝟎−𝟏𝟏[𝑪𝑭𝑼−𝟏 ∗ 𝒎𝒊𝒏−𝟏] 
 
Latent Period 
Rise Period 
Burst Size 
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Figure 38: One-step growth for the Binding Rate determination. 
 
d) Burst Size 
 
The final formula taken into account for the determination of the 
burst size value is: 
𝑩𝒖𝒓𝒔𝒕 𝒔𝒊𝒛𝒆 =
𝑭𝟏𝟒−𝟏𝟔𝒎𝒊𝒏
(𝑻𝟎+𝒎𝒊𝒏 − 𝑼𝟒𝒎𝒊𝒏)
            (𝟏𝟖. 𝒂) 
 
Where T is the starting concentration of total phage immediately 
after the inoculation of phages in bacteria; U is the number of 
unadsorbed phage; F is the final concentration of phages after the 
latent period. The number of plaques (PFUs), as function of the 
time, can be considered roughly constant until 12 minutes (latent 
period), so the difference between T0
+
min and U4min in the number of 
plaques counted onto the plates, is approximated to 1. The burst 
size value is: 
 
𝑬𝒙𝒑𝒆𝒓𝒊𝒎𝒆𝒏𝒕𝒂𝒍 𝑩𝒖𝒓𝒔𝒕 𝑺𝒊𝒛𝒆 =
𝟒𝟖𝟒~𝟓𝟎𝟕 ∗ 𝟏𝟎𝟒
(𝟑𝟒 − 𝟑𝟑) ∗ 𝟏𝟎𝟒
≈ 𝟒𝟖𝟒~𝟓𝟎𝟕 [𝑷𝑭𝑼] 
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e) Decay Rate 
 
The 7-day decay experiment results are shown in the following 
table: 
 
Decay Rate Experiment 
(PFU/mL) 
Replicate 
1 
Replicate 
2 
Replicate 
3 
0 hours 2.30E+09 1.60E+09 1.60E+09 
29 hours 6.00E+08 3.00E+08 3.00E+08 
99 hours 7.40E+07 5.40E+07 6.10E+07 
121 hours 3.10E+07 3.70E+07 3.70E+07 
147 hours 2.10E+07 2.50E+07 2.50E+07 
 
Using the equation (16) for the fitting, the phage decay rate 
represents the slope of the straight line (Figure 39): 
 
 
𝑬𝒙𝒑𝒆𝒓𝒊𝒎𝒆𝒏𝒕𝒂𝒍 𝑫𝒆𝒄𝒂𝒚 𝑹𝒂𝒕𝒆 = 𝟎. 𝟎𝟎𝟏  [𝒎𝒊𝒏−𝟏] 
 
  
 
Figure 39: Decay Rate Experiment. 
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4.8 Comparison between experimental and 
model optimized parameter values 
 
Comparison 
Parameter 
Values 
Growth 
Rate 
 [min-1] 
Binding 
 Rate  
[CFU-1min-1] 
Burst 
size 
[PFU] 
Latent 
period 
[min] 
Decay 
Rate 
[min-1] 
Model 0.0213 1.75E-10 500 9+3 0.009 
Experiment 0.0219 1.92E-11 484-507 12 0.001 
 
The previous table summarizes the parameter set determined by 
model optimization and that determined from experiments. The 
values reported do not show significant differences demonstrating 
that the automatic global minimum research and the CV method, 
implemented in the software system, are able to return, as a result 
of the optimization, parameter values that are meaningful and 
realistic. In other word, they are close to the reality, a good 
representation of the phage-host interaction experimentally 
observable. In particular, the growth rates are very similar because 
the bounds adopted for the parameter optimization are in the range 
of the experimental values. Taking into consideration the starting 
period (3 minutes) of shaking, programmed by the microplate 
reader experiment in order to make the optical density measurement 
uniform, even the latent period values coincide. While the slight 
differences displayed for the remaining values may be determined 
by two factors: first, due to the presence of a high variability in 
both observed and predicted value, especially in the count of PFUs; 
second, the model may need further modifications, for example, 
adsorption rate and latent period may depends on the initial host 
density or some parameters may vary with time (or better with the 
physiological condition of the host).  
 
 
4.9 A5mainPREDITCION.m-Validation step 
 
The script A5mainPREDICTION.m was used at first for the 
validation of the implemented software system. Considering the 
optimized model parameters and the training data, the program is 
able to predict the starting concentration of phages in unknown 
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samples. The test realized for the model validation consists of the 
prediction of various specimen sets coming from five different 
microplate reader experiments. The total testing set is composed by 
235 samples in which the starting concentration of phages is 
known. The testing data were obtained using the same protocol 
(section 3.1.4) and cell starting OD600 of the training set. As result, 
the program is able to return the CFU/ml, PFU/mL, MOI and the 
plot of every sample (Figure 40-41). 
 
 
Figure 40: The results of the prediction in the command window. 
 
 
 
 
 
 
 
Figure 41: Examples of the prediction for different mean curves. 
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The validation of the model parameter value comparing predicted 
and theoretical concentrations of phages has shown a probability of 
the 91.9% to get correct results. In particular, the 8.1% of error 
involves the prediction of mean curves having lower MOI values 
(<0.006), this means lower concentrations of phages considering 
the cell number roughly constant. A possible explanation for that 
might be the presence of a high variability in the curves over time 
of the samples with low phage concentration, as the reflection of an 
issue at an operative point of view (Figure 42). Indeed, when the 
bacteriophages are strongly diluted, the probability to withdraw and 
inoculate the same number of phages in the different samples is 
low. This could be also the reason why the 8.1% of no-correct 
prediction may not be considered as error, also due to the fact that 
the phage dilutions for the testing set are known only theoretically 
(from the serial dilution), so the variation in the number of phages 
for each sample could determine a different prediction. Another 
observation is that the error in the prediction may be determined by 
the use of a starting OD value different from that of the training set 
and the error probability grows with the increase of the gap 
between the initial conditions for training and testing sets.  
 
 
Figure 42: The variability for the samples of every phage dilution. 
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Chapter 5 
5 Conclusion and future directions 
5.1 Conclusion 
The software system developed demonstrates to have many 
advantages. Firstly, it is capable of predicting, with high reliability, 
one or more concentrations of phages more quickly than the 
traditional Plaque Assay method. Indeed, the waiting time for the 
results is not in the order of up to 24 hours but  about 90 minutes. 
Secondly, it shows to be good and useful for differential 
comparisons. For instance, it could be adopted for the monitoring 
of a variable over time, measuring the concentration of phages at 
different time intervals and comparing the results. Lastly, the 
software system is able to give a meaning to the obtained 
experimental data, making inference about the unknown model 
parameter set values which describe the kinetic interaction between 
phage and their host.  
 
5.2 Future directions 
Future work will be aimed at testing the software system with 
different types of cells and/or phages. As proof of this concept, the 
flexibility of the program was evaluated using a different strain of 
E. Coli (MG1655) with T7∆gp5 phages. The results after cross 
validation (Figure 43) show a good fitting of the experimental data 
and the prediction program was tested on 15 samples obtaining a 
probability of correct prediction of 93%.  As mentioned above, it 
will be important, in particular, to use as training and testing set, for 
each evolution cycle, the data from the interaction of new evolved 
bacteria that are resistant to the starting phages and new mutated 
phages capable of infecting and defeating the described resistant 
hosts. 
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Figure 43: The curve fitting results of the interaction between MG1655 and T7∆gp5. 
A second important future extension of the project will involve the 
implementation and adaption of the software system on Arduino 
electronic platform for the Bioreactor output monitoring and 
evaluation. In particular, creating an optical density reader and 
adding it at the outflow of the Bioreactor (cellstat) opportunely 
connected with a fresh cell culture (chemostat), it will possible to 
automatically obtain the experimental curves of phage-host 
interaction, without the use of an external microplate reader. In this 
way, the prediction of the unknown concentration of phages will be 
in near real-time.  
 
One last future orientation will be the modification of the model for 
a single-cell level. Indeed, using microfluidic systems and 
microscopy techniques, it will be possible to observe the dynamic 
behaviour between phages and bacteria taking in consideration a 
limited number of them (Figure 44). 
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Figure 44: An example of the growth curve as result of the interaction of 100 cells and 10 
phages. 
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Appendix-Matlab Codes 
1 A1mainPLOT.m 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%   A1mainPLOT.m  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
  
%%%%%%%%%%%%%%Rules for the plot%%%%%%%%%%%%%% 
%%1) qimron protocol 
%%2) starting od from the spectrophotometer of 0.2-0.3 
%%3) microplate: every row is a replicate, every column a 
different 
%%dilution, the first one is the negative control (no 
phages) after 
%%10^-1...10^-8 
%%4) MOI no over 8! 
  
  
%%%%%% PLOT results with Qimron's protocol 
  
clear all  
close all 
clc 
warning('off','all') 
  
%% DATA IMPORT 
fprintf('****ATTENTION: Select the excel file with ONLY the 
microplate reader OD values!!!****\n\n ****PRESS Ctrl+C to 
exit from the program****\n\n') 
[FileName,PathName,FilterIndex] = uigetfile('*.*'); 
%%10/12/2014  
     
data= xlsread(strcat(PathName, FileName));  
[r,c]=size(data); 
t=0:300:300*(c-1); 
  
  
%% BLANK 
media=input('*Do you want to setup the blank manually 
(press 1)\n or automatically using the first line of the 
microplates (press2)? '); 
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if media==1 
     
blank=input('*Write the OD tecan value for the blank (for 
example 0.08 (LB) or 0.07 (2xYT)): '); 
  
%%%CONTROL%%% 
if (blank>1 || length(blank)>1 || isnumeric(blank)==0)  
      error('***Wrong number of input arguments***') 
end 
%%%%%%%%%%%%% 
  
shiftBLANK=0; 
else if media==2 
        blank=mean(data(1:12,1)); 
        shiftBLANK=12; 
    else error('***ERROR: NO VALID INPUT; PLEASE PRESS 1 OR 
2!*** \n') 
    end 
end 
  
colori={'Red','Orange','Yellow','Green','Blue','LightBlue',
'Plum','Purple','Magenta','Olive','Maroon'}; 
  
%% NUMBER OF REPLICATIONS 
numREP=input('*Key the number of replicates for every 
dilution (for example 5): '); %7 
  
%%%CONTROL%%% 
if (numREP>8 || length(numREP)>1 || isnumeric(numREP)==0)  
    %test if numREP is a number, a single value, <=8! 
    error('***Wrong number of input arguments***') 
end 
%%%%%%%%%%%%% 
  
replicates=[]; 
  
  
line1=2+shiftBLANK; %negative control is the first line 
line2=input('*Write the number of dilutions for every line, 
including the negative control (for example 12): '); %12 
  
%%%CONTROL%%% 
if (line2>12 || length(line2)>1 || isnumeric(line2)==0)  
    %test if numREP is a number, a single value, <=8! 
    error('***Wrong number of input arguments***') 
end 
%%%%%%%%%%%%% 
shiftLINE=line2; 
line2=line2+shiftBLANK; 
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for i=1:numREP 
    replicates(:,:,i)=data(line1:line2,1:c); 
    line1=line1+shiftLINE; 
     line2=line2+shiftLINE; 
end 
  
%% NEGATIVE CONTROLS, NO PHAGE 
NC=[]; 
nc=1; 
for i=1:numREP 
 NC(:,i)=data(nc,1:c); 
     nc=nc+shiftLINE; 
end 
  
  
%% BLANK SUBSTRACTION 
NC=NC-blank; 
replicates=replicates-blank; 
  
  
%% PLOT 
[m,n,d]=size(replicates); 
t=t/60; %in minutes 
  
for i=1:numREP 
    figure(i) 
    title('OD TECAN MEASUREMENT') 
    hold on 
    plot(t, NC(:,i),'color',rgb('Black'),'LineWidth',2.5) 
    legendInfo{1}=['NEGATIVE CONTROL']; 
    for j=1:m 
plot(t, 
replicates(j,:,i),'color',rgb(colori(j)),'LineWidth',2.5) 
legendInfo{j+1} = ['DILUTION NUM: ' num2str(j)]; % or 
whatever is appropriate 
  
end 
  
xlabel('TIME in minutes') 
ylabel('OD') 
grid on 
    hold off 
legend(legendInfo) 
end 
startTRAINING=input('*Do you want to proceed with the mean 
curves calculation? YES(1) NO(2) '); 
  
if startTRAINING==1 
%% CUTTING TIME (90 MIN) 
minutesCUT=input('*Key the number in minutes for the 
cutting (for example 90): '); %min 
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%%%CONTROL%%% 
if (minutesCUT>t(end) || length(minutesCUT)>1 || 
isnumeric(minutesCUT)==0)  
    %test  
    error('***Wrong number of input arguments***') 
end 
%%%%%%%%%%%%% 
  
cut=(minutesCUT+5)/5; 
t=t(1:cut); 
replicates=replicates(:,1:cut,:); 
NC=NC(1:cut,:); 
  
  
%% 2D MATRIX CREATION 
%the first rows are the red curves in time (e.g. dilution 
10^0) 
  
curves=[]; 
shift=0; 
  
for y=1:m  % size(replicates)  
    for i=1:d % numREP 
        curves(i+shift,:)=replicates(y,:,i); 
    end 
    shift=shift+d; 
end 
  
% figure; %test plot 
% a=1; 
% b=d; 
% for y=1:m 
%     subplot(6,2,y) 
%     plot(t,curves(a:b,:)) 
%     a=a+d; 
%     b=b+d; 
% end 
  
 % create a 2d matrix only with good data 
  
  setCHOOSING=input('*Press 1 for automatical training set 
creation,\n 2 for manual traning creation (only for 
experts): '); 
   
  if (setCHOOSING==1) 
      int1=input('*Interval of replicates (for example [1 
5]): ');  %[4 6] 
       
      %%%CONTROL%%% 
      if (int1(2)<int1(1) || length(int1)~=2 || 
isnumeric(int1)==0)  
      %test  
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      error('***Wrong number of input arguments***') 
      end 
      %%%%%%%%%%%%% 
       
      int2=input('*Interval of dilutions (for example [3 
7]): '); %[1 7] 
       
      %%%CONTROL%%% 
      if (int2(2)<int2(1) || length(int2)~=2 || 
isnumeric(int2)==0)  
      %test  
      error('***Wrong number of input arguments***') 
      end 
      %%%%%%%%%%%%% 
       
      goodDATA=[]; 
      ii=(int2(2)+1)-int2(1); 
      a=(int2(1)-1)*d+int1(1); 
      b=(int2(1)-1)*d+int1(2); 
       meanNC=mean(NC(:,int1(1):int1(2))'); 
            
      % d is the numer of replicates 
      for i=1:ii 
           
          goodDATA=[goodDATA; 
              curves(a:b,:)]; 
          a=a+d; 
          b=b+d; 
      end 
      replicates4CURVE=((int1(2)+1)-int1(1))*ones(ii,1); 
       
  else if (setCHOOSING==2) 
           
       
  goodDATA=input('*Key the curves for the training set 
manually: (for example [curves(5:7,:);\n curves(12:14,:);\n 
curves(19:21,:);\n curves(26:28,:);\n curves(33:35,:);\n 
curves(40:42,:);\n curves(47:49,:)]:\n '); 
  replicates4CURVE=input('*Digit the number of replicates 
for every dilution of the training set: (for example [3;\n 
3;\n 3;\n 3;\n 3;\n 3;\n 3]:\n '); 
   
      else error('\n***ERROR!!!!!!!!!! Input no valid! 
Please run the program again!***\n\n') 
      end 
  end 
   
    figure; %test plot 
    plot(t,goodDATA) 
    title('Good data') 
  
   %% DATA SUMMARY AND MEAN CURVES CALCULATION 
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   % fit data from max to min with a sigmoidal function 
    [infoMIDPOINT] = sigmFITdata(goodDATA,t); 
  
   % Average of the different curves 
    meanCURVES=[];   
    stdMIDPOINT=[];  %standard deviation of the midpoints 
from infoMIDPOINT 
    meanMIDPOINT=[];   % mean value of the midpoints from 
infoMIDPOINT 
    linea1=1; 
    linea2=replicates4CURVE(1); 
        
       for i=1:length(replicates4CURVE) 
            
           
meanCURVES(i,:)=mean(goodDATA(linea1:linea2,:),1); 
           
stdMIDPOINT(i,1)=std(infoMIDPOINT(linea1:linea2,1)); 
           
stdMIDPOINT(i,2)=std(infoMIDPOINT(linea1:linea2,2)); 
           
meanMIDPOINT(i,1)=mean(infoMIDPOINT(linea1:linea2,1)); 
           
meanMIDPOINT(i,2)=mean(infoMIDPOINT(linea1:linea2,2)); 
           linea1=linea1+replicates4CURVE(i); 
           if (i<length(replicates4CURVE)) 
           linea2=linea2+replicates4CURVE(i+1); 
           else 
               linea2=linea2+replicates4CURVE(end); 
           end 
       end 
        
    % MIDPOINT for the mean curves 
    [infoMIDPOINTmean] = sigmFITdata(meanCURVES,t);   
  
    figure;  
    
    title('OD TECAN MEASUREMENT- MEAN CURVES') 
    grid on 
    hold on 
    plot(t, meanNC,'color',rgb('Black'),'LineWidth',2.5) 
   [mm,nn]=size(meanCURVES); 
    color=int2(1); 
    legendInfo{1}=['NEGATIVE CONTROL']; 
for i=1:mm 
plot(t, 
meanCURVES(i,:),'color',rgb(colori(color)),'LineWidth',2.5) 
legendInfo{i+1} = ['DILUTION NUM: ' num2str(i)]; 
color=color+1; 
end 
legend(legendInfo) 
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xlabel('TIME in minutes') 
ylabel('OD') 
%plot(meanMIDPOINT(:,1),meanMIDPOINT(:,2),'g*') 
herrorbar(infoMIDPOINTmean(:,1),infoMIDPOINTmean(:,2),stdMI
DPOINT(:,1))  
% the standard deviation reported on the midpoint of the 
mean curves (x,y) 
hold off 
  
%% DATA SAVING 
save('tecan12122014','t','goodDATA','NC','meanCURVES','mean
NC','infoMIDPOINT','infoMIDPOINTmean','stdMIDPOINT','blank'
,'colori','int1','int2') 
  
else if startTRAINING==2 
        error('*****************END****************') 
    else error('\n***ERROR!!!!!!!!!! Input no valid! Please 
run the program again!***\n\n') 
    end 
end 
disp('**************END**************')        
  
 
1.1 sigmFITdata.m 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%   sigmFITdata.m  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
function [infoMIDPOINT] = sigmFITdata(matrixDATA,t) 
  
%%%input: matrixDATA with different curves as rows and the 
time as columns 
[row,col]=size(matrixDATA); 
  
% find the maximum point of every curve 
maxCURVES=max(matrixDATA(:,3:end),[],2);  
     
    for i=1:length(maxCURVES) 
         
    
indexMAX(i)=max(find(matrixDATA(i,3:end)==maxCURVES(i)))+2; 
    end 
             
       
       %% FITTING 
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       % general sigmoidal equation 
        
       f = @(p,x) p(1)-((p(1) ./ (1 + exp(-(x-
p(2))/p(3))))); 
        
       opt=optimset('TolX',1e-
6,'MaxIter',300,'MaxFunEvals',1e2); %'Display','iter', 
        
       infoMIDPOINT=[]; 
        
       for i=1:row  
        
       % consider only the descending part of the curves 
       sigmaDATA=matrixDATA(i,indexMAX(i):end);  
       tDATA=t(indexMAX(i):end); 
        
       midPOINT=(max(sigmaDATA)-min(sigmaDATA))/2; 
        
       global yo p 
       yo=midPOINT; 
       middleTIME=ceil(length(t)/2); 
       xo=t(middleTIME); %starting point for the F(xo) 
research 
       xi=tDATA(1):0.01:tDATA(end); %increase points for 
the fitting 
       
       p = nlinfit(tDATA,sigmaDATA,f,[0 20 50 5],opt);  
       %%[] is p0 starting coefficient 
        
            
       %[curve,goodness]=fit(tDATA',sigmaDATA','a + b ./ (1 
+ exp(-(x-m)/s))','start',[0 20 50 5]) 
        
  
       xx=fzero(@sigmoide,xo,opt);  
       % the function sigmoide is the fitting sigmoidal 
curve shifted! 
       % x0=80; initial point for the research 
  
       infoMIDPOINT(i,1)=xx;   %% x value 
       infoMIDPOINT(i,2)=midPOINT; %% y value 
  
% test plot %find the max points and from there I start 
with the sigmoidal fitting 
% 3 means that I start to consider the maximums after 10 
minutes,(at time 0 no max considerable) 
% % % % % % % % % % % %         figure; %test plot 
% % % % % % % % % % % %         hold on  
% % % % % % % % % % % %         grid on 
% % % % % % % % % % % %         
plot(t(3:end),matrixDATA(:,3:end)) 
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% % % % % % % % % % % %             
% % % % % % % % % % % %         
plot(t(indexMAX),maxCURVES,'r*') 
% % % % % % % % % % % %         
% % % % % % % % % % % %         plot(tDATA,sigmaDATA) 
% % % % % % % % % % % %         
line(xi,f(p,xi),'color','r') 
% % % % % % % % % % % %         plot(xx,yo,'k*') 
% % % % % % % % % % % %         plot([xx xx],[0 yo]) 
% % % % % % % % % % % %         hold off 
% % % % % % % % % % % %         refresh 
% % % % % % % % % % % %         pause() 
  
       end 
       
end 
  
 
 
1.2 sigmoide.m 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%   sigmoide.m  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
  
function [y] = sigmoide(x) 
global yo p 
y=p(1)-((p(1) ./ (1 + exp(-(x-p(2))/p(3))))); 
y=y-yo; % the curve is shifted of yo. 
end 
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A2odCFUcalibration.m 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%   A2odCFUcalibration.m  
%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
clear all 
close all 
clc 
warning('off','all') 
%%%%%%%%%%%%%%%%%%new calibration tecan OD CFU/ML 
  
%% DATA IMPORT 
fprintf('****ATTENTION: Select the excel file with ONLY 
spectrophotometer OD values!!!****\n\n ****PRESS Ctrl+C to 
exit from the program****\n\n') 
[FileName,PathName,FilterIndex] = uigetfile('*.*'); 
%odCFUdata 12-12-2014 
data= xlsread(strcat(PathName, FileName)); 
x=data(1,:)'; 
y=data(2,:)'; 
  
%od=[0 0.150 0.214 0.329 0.495 0.7]; %spectrophotometer 
% y=[0 0 0 5.2*10^7 6.5*10^7 5.0*10^7 6.3*10^7 6.4*10^7 
5.5*10^7 7.3*10^7 6.6*10^7 7.5*10^7 1.64*10^8 1.47*10^8 
1.46*10^8 3.8*10^8 2.5*10^8]; 
% x=[0 0 0 0.150 0.150 0.150 0.214 0.214 0.214 0.329 0.329 
0.329 0.495 0.495 0.495 0.7 0.7]; 
  
%% CALIBRATION 
choice=input('*Press 1 for automatical calibration, 2 for 
manual calibration (only for experts): '); 
  
if choice==1 
  
fittedmodel=fit(x,y,'poly1','Robust','LAR') 
P=coeffvalues(fittedmodel); 
  
% % % extract the *interpolated* curve from the figure 
% % X=get(h,'XData'); 
% % Y=get(h,'YData'); 
else if choice==2 
        cftool(x,y) 
        %%%% save here the cftool results!! 
        disp('*It is advisable to use a LINEAR function!') 
        disp('*PLEASE save the cftool fitting session\n 
(from the maximized cftool window,\n choose "Save to 
Workspace" from the "fit" menu\n then click OK'); 
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        disp('*Press a button to continue after the 
fitting!') 
        pause() 
        fittedmodel 
        goodness 
        output 
        P=coeffvalues(fittedmodel); 
  
  
         
    else error('\n***ERROR!!!! INPUT NO VALID!! Please run 
the program again!!*** \n\n') 
    end    
end 
 figure; 
h=plot(fittedmodel,x,y); 
grid on 
legend('experiment data','fitting equation','FontSize',18) 
xlabel('OD','FontSize',18) 
ylabel('CFU/ml','FontSize',18) 
  
  
%% CFU/mL DETERMINATION 
c=input('\n\n*Input CFU/mL :\n for MANUAL press 1;\n with 
GINPUT press 2;\n from the STARTING OD INFO press 3: '); 
if c==1 
CFUml=input('*Key the CFU/ml (for example 6*10^7  or 
60000000): '); %6*10^7 
else if c==2 
        [startOD, CFUml]=ginput(1); 
    else if c==3 
            startOD=input('*Write the starting 
SPECTROPHOTOMETER OD value (es 0.2): ') 
             
            %%%CONTROL%%% 
      if (startOD<0 || startOD>1 || length(startOD)>1 || 
isnumeric(startOD)==0)  
            error('***Wrong number of input arguments***') 
      end 
            %%%%%%%%%%%%% 
            CFUml=fittedmodel(startOD); 
        else error('\n***ERROR!!!! INPUT NO VALID!! Please 
run the program again!!*** \n\n') 
        end 
    end 
end 
  
save('odCFUcalibration','P','fittedmodel','CFUml') 
disp('**************END**************') 
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3 A3mainFIT.m 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%   A3mainFIT.m  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
clear all 
close all 
clc 
warning('off','all') 
%%%%%%%% FITTING MICROPLATE READER DATA TO THE MODEL 
  
%% DATA LOADING 
load('tecan12122014') 
warning('off','all') 
  
wellCELLS=0.18; %%qimron protocol 
wellPHAGE=0.02; 
  
%% EQUATION FOR OD-CFU/mL CALIBRATION 
  
choice=input('*Do you use the previous OD-CFU/ml 
calibration? Digit 1 (YES), 2 (NO): '); 
  
if choice==2 
    fprintf(' \n ***Please run the A2odCFUcalibration 
program!!*** \n') 
else if choice==1 
         load('odCFUcalibration.mat') 
         [mm,nn]=size(meanCURVES); 
      p1 =P(1);  
      p2 =P(2); 
PFUml=input('*Key the PFU/ml for the HIGHEST concentration 
considered(for example 3*10^10  or 30000000000): '); 
%3*10^10 
%PFUml=3*10^10; 
MOI=(PFUml*wellPHAGE)/(CFUml*wellCELLS); %for the highest 
concentration (lowest dilution) 
conversionSPECTRtecan=3.4; %OD difference beteween the 
spectrophotometer and the tecan 
  
od1=(meanCURVES>=0.02).*meanCURVES*conversionSPECTRtecan; 
od2=(meanNC>=0.02).*meanNC*conversionSPECTRtecan; 
for i=1:mm 
cfuMEANcurves(i,:)=(wellCELLS+wellPHAGE)*fittedmodel(od1(i,
:)); 
end 
cfuMEANcurves=(cfuMEANcurves>=0).*cfuMEANcurves; 
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cfuMEANnc=(wellCELLS+wellPHAGE)*fittedmodel(od2); 
cfuMEANnc=(cfuMEANnc>=0).*cfuMEANnc; 
  
%% GROWTH RATE DETERMINATION 
figure; 
plot(t,cfuMEANnc) 
title('Experimental growth rate') 
grid on 
xlabel('TIME in minutes') 
ylabel('CFU') 
points=input('*Growth rate: choose two points 
automatically, the first and the last, (press 1)\n or 
manually, with ginput (press 2): '); 
  
if points==1 
t0=t(1); 
N0=cfuMEANnc(1);%ginput(1); 
t1=t(end); 
N1=cfuMEANnc(end);%ginput(1); 
else if points==2 
[t0,N0]=ginput(1); 
[t1,N1]=ginput(1); 
    else 
        fprintf('*** ERROR!! No VALID INPUT!!***\n') 
    end 
end 
  
growthRATE = ((log10(N1)-log10(N0))*2.303)/(t1 - t0) %in 
min^-1 
grow1=growthRATE-(growthRATE/5); 
grow2=growthRATE+(growthRATE/5); 
  
%% MAIN, FIRST STEP: parameter optimization for each 
dilution 
  
global hystory  
  
figure(100); 
   
    grid on 
    hold on 
  
    color=int2(1); 
for i=1:mm 
plot(t, 
cfuMEANcurves(i,:),'*','color',rgb(colori(color)),'LineWidt
h',1.5) 
  
legendInfo{i} = ['DILUTION NUM: ' num2str(i)]; 
color=color+1; 
end 
99 
 
 str2 = sprintf('OD TECAN MEASUREMENT 12/12/2014 CFU/ML= 
%1.2e PFU/ML=%1.2e', CFUml, PFUml); 
title(str2) 
 legend(legendInfo)    
xlabel('TIME in minutes') 
ylabel('CFU') 
hold on 
  
 %% solve the model system 
  
opt=optimset('TolX',1.0e-
5,'MaxIter',15,'MaxFunEvals',1e4);%,'OutputFcn',@PlotIterat
es); %'Display','iter', 
  
%%%%%%%%%%%%%%%%%%%%%%Initial conditions%%%%%%%%%%%%%%%%%% 
esp=int2(1)-1; 
for i=1:mm 
    S0=cfuMEANcurves(i,1); %CFU 
    V0=PFUml*wellPHAGE/10^esp; %PFU 
    I0=0; 
    %ratio=1/(10^6); 
    R0=0;%S0*ratio; 
  
    hystoryMATRIX(:,:,i)=[S0; R0; I0; V0]; 
    esp=esp+1; 
end 
  
integrationTIME=[0 t(end)]; 
tspan=integrationTIME; 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%GLOBAL 
SEARCH%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
 %load('mainFITA3b') 
  
 color=int2(1); 
for k=1:mm 
    
hystory=hystoryMATRIX(:,:,k); 
  
if k==1 
a=growthRATE; % growth rate: up and down 
f=0; % mutation rate of bacteria 
K=6.1055; % latent period: left and  right 
m=0.0001038; % phage decay rate 
b=0.280019e-09; % binding rate of phage: amplitude of the 
curve 
h=150.1286; % burst size 
P0=[a b h K m]; % starting value for the parameters 
  
%%%%%%%%%%LOWER AND UPPER BOUNDS%%%%%%%%%%%%%%%% 
% LB=[grow1 0 0 0 0.0001];    
100 
 
% UB=[grow2 1e-9 500 30 0.1]; 
LB=[grow1 0 0 0 0.00000001];    
UB=[grow2 1e-9 800 30 0.01]; 
  
%NUMBER OF VALUES TAKEN IN CONSIDERATION FOR EACH LOWER AND 
UPPER BOUND% 
comNUMpar=[3 4 3 4 2];  %288 starting points 144 
  
else 
P0=ParNEW(1,:); 
LB=P0-P0/5; 
UB=P0+P0/5; 
LB(1)=grow1;%P0(1)-P0(1)/10;  %%the interval for the growth 
rate 
UB(1)=grow2;%P0(1)+P0(1)/10; 
comNUMpar=[3 3 3 3 1]; %108 starting points 81 
end 
  
for i=1:length(LB) 
    comb{i}=linspace(LB(i),UB(i),comNUMpar(i)); 
end 
  
[X,Y,Z,W,Q] = 
ndgrid(comb{1},comb{2},comb{3},comb{4},comb{5}); 
startP=[X(:),Y(:),Z(:),W(:),Q(:)]; 
custpts = CustomStartPointSet(startP); 
  
  
problem = 
createOptimProblem('lsqcurvefit','x0',P0,'objective',@helpe
r,'lb',LB,'ub',UB,'xdata',t,'ydata',cfuMEANcurves(k,:),'opt
ions',opt); 
%gs = GlobalSearch('Display','iter','MaxTime',60); 
 ms = 
MultiStart('UseParallel','always','StartPointsToRun','bound
s','Display','iter','PlotFcns',@gsplotbestf);%,'MaxTime',60
);% 
[PmultiBest,errormultiBest,exitflag] = 
run(ms,problem,custpts) 
ParNEW(k,:)=PmultiBest; 
  
%%%% delay model solution%%%% 
% 1. define the state  
state=+1; 
% 2. register this function as an event function 
options = ddeset('Events',@MyEventFunction);  
% 3. start a stopwatch timer, if you already use one, 
define a new one: tic(ticID) 
tic; 
  
sol=dde23('cairns',ParNEW(k,4),hystory,tspan,options,ParNEW
(k,:)); 
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cells=sol.y(1,:)+sol.y(3,:); 
cells=(cells>=0).*cells; 
% phage=sol.y(3,:)'+sol.y(4,:)'; 
time=sol.x; 
figure(100) 
hold on 
plot(time,cells,'color',rgb(colori(color)),'LineWidth',2); 
%tint,phage); 
color=color+1; 
end 
  
save('mainFITA3b','cfuMEANcurves','PFUml','wellCELLS','well
PHAGE','hystoryMATRIX','growthRATE','ParNEW','LB','UB','con
versionSPECTRtecan') 
  
    else  
        fprintf('***ATTENTION! ERROR: NO VALID INPUT. 
Please run the programe again!') 
    end 
end 
  
disp('**************END**************') 
 
3.1 helper.m 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%   helper.m  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
  
function [cells2,VALUE]=helper(Par,t) 
global hystory 
tt=t; 
%% 1. define the state  
state=+1; 
%% 2. register this function as an event function 
options = odeset('Events',@MyEventFunction);  
  
%% 3. start a stopwatch timer, if you already use one, 
define a new one: tic(ticID) 
tic; 
  
%% Run the model 
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sol=dde23('cairns',Par(4),hystory,tt,options,Par); 
  
load('v.mat') 
if VALUE>0 
         load('defaultDDEsolERR') 
         
end 
  
time=sol.x; 
cells=sol.y(1,:)+sol.y(3,:); 
cells2=interp1(time,cells,tt); 
cells2=(cells2>=0).*cells2; 
    
end 
  
  
 
3.2 cairns.m 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%   cairns.m  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
function v = cairns(t,y,Z,Par) 
S=y(1); 
R=y(2); 
I=y(3); 
V=y(4); 
  
a=Par(1); 
f=0; 
b=Par(2); 
h=Par(3); 
m=Par(5); 
  
%% delay 
ylag=Z; 
v=zeros(4,1); 
    
v(1)=a*S-f*S-b*S*V; 
v(2)=a*R+f*S; 
v(3)=b*S*V-b*ylag(1)*ylag(4); 
v(4)=h*b*ylag(1)*ylag(4)-b*S*V-m*V; 
 
end 
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3.3 MyEventFunction.m 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%   MyEventFunction.m  
%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
%% Define the event function 
function [VALUE, ISTERMINAL, DIRECTION] = 
MyEventFunction(t,y,Z,state) 
%%The event function stops the intergration is VALUE == 0 
and  
%%ISTERMINAL==1 
  
%%a. Define the timeout in seconds 
TimeOut = 3; %sec 
%%  
%%b. The solver runs until this VALUE is negative (does not 
change the sign) 
    VALUE = toc-TimeOut; 
    save('v','VALUE') 
  
%%c. The function should terminate the execution, so 
ISTERMINAL = 1; 
  
%%d. The direction does not matter 
DIRECTION = 0; 
 
end 
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A4mainCROSS.m 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%   A4mainCROSS.m  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
%%%%%%%% Parameter optimization 
  
clear all 
close all 
clc 
warning('off','all') 
%%%%%a=0.017; growth rate 
%%%%%%m=0.0001 
  
%% DATA LOADING 
choice=input('Do you use the previous fitting parameters? 
Digit 1 (YES), 2 (NO): '); 
  
if choice==2 
    fprintf(' \n ***Please run the A3mainFIT program!!*** 
\n') 
else if choice==1 
         load('odCFUcalibration.mat') 
         load('tecan12122014.mat') 
         load('mainFITA3b') 
         PParNEW=ParNEW; 
  
global hystory trainHYSTORY testHYSTORY K 
  
Kvect=PParNEW(:,5); 
  
Ydata=cfuMEANcurves; 
  
figure(100); 
   
    grid on 
    hold on 
  
[mm,nn]=size(meanCURVES); 
color=int2(1); 
for i=1:mm 
plot(t, 
cfuMEANcurves(i,:),'*','color',rgb(colori(color)),'LineWidt
h',1.5) 
  
legendInfo{i} = ['DILUTION NUM: ' num2str(i)]; 
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color=color+1; 
end 
 str2 = sprintf(' COMPARISON: OD MEASUREMENT-DELAY MODELS 
(CROSS VALIDATION) CFU/ML= %1.2e PFU/ML=%1.2e', CFUml, 
PFUml); 
title(str2) 
     
xlabel('TIME in minutes') 
ylabel('CFU') 
  
 opt=optimset('TolX',1.0e-
5,'MaxIter',15,'Display','iter','MaxFunEvals',1e4);%,'Outpu
tFcn',@PlotIterates); 
  
 Par=[]; 
hystory=hystoryMATRIX; 
integrationTIME=[0 t(end)]; 
tspan=integrationTIME; 
  
%% CROSS VALIDATION 
  
x_sample=t; 
y_sample=cfuMEANcurves; 
n_sample=size(y_sample,1); 
K=n_sample; 
index=crossvalind('kfold',n_sample,K) 
  
ParMATRIX=[]; 
error=[]; 
CellMATRIX=[]; 
tic 
for i=1:K 
    %iTESTsample=find(index==i); % i è il numero del 
campione preso come test in leave one out! 
    test = (index==index(i)); train = ~test; 
 %train_x = x_sample(train,:); 
 train_y = y_sample(train,:); 
 trainHYSTORY=hystory(:,:,train); 
 ParINIT=median(PParNEW(train,:)) % Starting parameter set: 
median of the traning set parameters. 
  
  %test_x  = x_sample(test,:); 
 test_y  = y_sample(test,:); 
 testHYSTORY=hystory(:,:,test); 
  
[ParNEW,resnorm,residual,exitflag,output] = 
lsqcurvefit(@helper4,ParINIT,t,train_y,LB,UB,opt); 
ParMATRIX(index(i),:)=ParNEW 
sol=dde23('cairns',ParMATRIX(index(i),4),testHYSTORY,tspan,
[],ParMATRIX(index(i),:)); 
  
z=interp1(sol.x,sol.y(1,:),t); 
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error(index(i))=sum((y_sample(index(i),:)-z).^2) 
tint = linspace(integrationTIME(1), integrationTIME(2)); 
yint = deval(sol,tint); 
cells=yint(1,:)'; 
CellMATRIX(index(i),:)=cells'; 
    
     
end 
toc 
  
MINerror=min(error); 
optimalPAR=ParMATRIX(find(error==MINerror),:); 
save('crossRESULTS2median','ParMATRIX','optimalPAR','error'
,'hystory','legendInfo') 
  
%%%%%%%%%%%%%%%% after cross validation %%%%%%%%%%%%%% 
  
%% PLOT 
load('crossRESULTS2median') 
  
ParNEWmainA4CROSS=optimalPAR; 
  
tint = linspace(integrationTIME(1), 
integrationTIME(2),100); 
cells=[]; 
  
for i=1:K 
sol=dde23('cairns',ParNEWmainA4CROSS(4),hystory(:,:,i),tspa
n,[],ParNEWmainA4CROSS); 
yint = deval(sol,tint); 
cells(:,i)=yint(1,:)'+yint(3,:)'; 
cells=(cells>=0).*cells; 
NORMcells(:,i)=cells(:,i)/cells(1,i); 
end 
  
color=int2(1); 
figure(100) 
hold on 
l=length(legendInfo); 
for i=1:mm 
plot(tint, 
cells(:,i),'color',rgb(colori(color)),'LineWidth',1.5) 
legendInfo{i+l} = ['MODEL-DILUTION NUM: ' num2str(i)]; 
color=color+1; 
end 
xlabel('TIME in minutes') 
ylabel('CFU') 
legend(legendInfo) 
f=figure(100); 
saveas(f,'crossMEDIAN.fig') 
  
else  
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        fprintf('***ATTENTION! ERROR: NO VALID INPUT. 
Please run the programe again!') 
    end 
end 
  
disp('**************END**************') 
 
 
 
4.1 helper4.m 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%   helper4.m  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
function cells=helper4(Par,t) 
global trainHYSTORY testHYSTORY K 
tt=t; 
  
for i=1:(K-1)  
sol=dde23('cairns',Par(4),trainHYSTORY(:,:,i),tt,[],Par); 
tint = linspace(tt(1),tt(end), length(tt)); 
yint = deval(sol,tint); 
cells(i,:)=yint(1,:)'+yint(3,:)'; 
end 
  
end 
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5 A5mainPREDICTION.m 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%   A5mainPREDICTION.m  
%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%% 
  
clear all 
close all 
clc 
  
%% DATA LOADING 
choice=input('Do you use the previous optimized fitting 
parameters? Digit 1 (YES), 2 (NO): '); 
  
if choice==2 
    fprintf(' \n ***Please run the A3mainFIT program!!*** 
\n') 
else if choice==1 
         load('odCFUcalibration.mat') 
         load('tecan12122014.mat') 
         load('mainFITA3b') 
         load('crossRESULTS2median') 
  
[mm,nn]=size(cfuMEANcurves); 
integrationTIME=[0 t(end)]; 
tspan=integrationTIME; 
ParNEWmainA4CROSS=optimalPAR; 
tint = linspace(integrationTIME(1), 
integrationTIME(2),100); 
cells=[]; 
  
  
%% DATA IMPORT 
  
fprintf('****ATTENTION: Select the excel file with ONLY the 
tecan OD values!!!****\n\n') 
[FileName,PathName,FilterIndex] = uigetfile('*.*'); 
     
unknown= xlsread(strcat(PathName, FileName)); 
unknown=unknown-blank; 
[MM,NN]=size(unknown); 
  
%% PREVIOUS MODEL FITTING 
openfig('crossMEDIAN.fig') 
  
for i=1:mm 
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%plot(t, cfuMEANcurves(i,:),'*','color',rgb(colori(i)))  
%%%data 
sol=dde23('cairns',ParNEWmainA4CROSS(4),hystory(:,:,i),tspa
n,[],ParNEWmainA4CROSS); 
yint = deval(sol,tint); 
cells(:,i)=yint(1,:)'+yint(3,:)'; 
NORMcells(:,i)=cells(:,i)/cells(1,i); 
%plot(tint, 
cells(:,i),'color',rgb(colori(i)),'LineWidth',1.5); 
%%%model 
  
end 
  
  
%%%% NORMcells and cfuUNKNOWN must have the same length 
if(NN>=nn) 
unknown=unknown(:,1:nn);  %cutting, in order to avoid 
artefacts 
else 
    tt=0:300:300*(NN-1); 
    for j=1:MM 
unknown(j,:)=interp1(tt,unknown(j,:),t); 
    end 
end 
  
%% OD-CFU/mL CALIBRATION 
conversionSPECTRtecan=3.4; 
p1 =   P(1);  
p2 =   P(2); 
  
od=(unknown>=0.02).*unknown*conversionSPECTRtecan; 
for i=1:MM 
cfuUNKNOWN(i,:)=(wellCELLS+wellPHAGE)*fittedmodel(od(i,:)); 
end; 
% cfuUNKNOWN=(wellCELLS+wellPHAGE)*(p1*od + p2);  %in CFU 
  
cfuUNKNOWN=(cfuUNKNOWN>=0).*cfuUNKNOWN; 
cfuUNKNOWN2=cfuUNKNOWN; 
  
%% NORMALIZZATION 
  
for i=1:MM 
cfuUNKNOWN(i,:)=cfuUNKNOWN(i,:)./cfuUNKNOWN(i,1); 
end 
  
%load('tecanFIT2results') 
  
figure; 
  
title('COMPARISON BETWEEN THE UNKNOWN DILUTION''S CURVE AND 
THE MODEL AFTER NORMALIZATION') 
xlabel('TIME in minutes') 
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ylabel('Num cells normalized with the start CFU/ml value') 
  
color=int2(1); 
for i=1:mm   
plot(tint, 
NORMcells(:,i),'color',rgb(colori(color)),'LineWidth',1.5); 
hold on 
grid on 
color=color+1; 
end 
plot(t,cfuUNKNOWN,'k','LineWidth',1.5); 
  
%% PREDICTION 
  
% %%%%%%%%%%%%%%%%%% Find the best coefficient of 
correlation %%%%%%%%%%%%%%% 
  
coeff=[]; 
  
pfu=squeeze(hystory(4,1,:)/wellPHAGE); 
  
for j=1:MM 
     
    cfuUNKNOWNinterp(j,:)=interp1(t,cfuUNKNOWN(j,:),tint);  
%%interpolation with 100 points-the same length of 
NORMcells 
  for i=1:mm 
   [R,p]=corrcoef(cfuUNKNOWNinterp(j,:),NORMcells(:,i));   
   coeff(j,i)=R(1,2); 
   pVALUE(j,i)=p(1,2); 
  end 
 end 
maxCORR=max(coeff,[],2); 
pVALUE 
  
  
for j=1:MM 
legendINFO=[]; 
indexMAXcorr(j)=find(coeff(j,:)==maxCORR(j)); 
pVALUEmaxCORR(j)=pVALUE(j,indexMAXcorr(j)); 
cc=indexMAXcorr(j)+(int2(1)-1); 
if (maxCORR(j)>=0.67 && pVALUEmaxCORR(j)<0.05) 
    count=j+2; 
figure(count) 
sampl = sprintf('%d',j); 
 hold on  
grid on 
% plot(tint,cfuUNKNOWNinterp(j,:),'k','LineWidth',2) 
% 
plot(tint,NORMcells(:,indexMAXcorr(j)),'color',rgb(colori(c
c)),'LineWidth',2); 
plot(t,cfuUNKNOWN2(j,:),'k','LineWidth',2) 
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plot(tint,cells(:,indexMAXcorr(j)),'color',rgb(colori(cc)),
'LineWidth',2); 
str = sprintf('MODEL PREDICTION FOR THE UNKNOWN DILUTION: 
SAMPLE NUM %s', sampl); 
title(str) 
xlabel('TIME in minutes') 
ylabel('Num cells in CFU/ml') 
legendINFO{1} =['UNKNOWN DILUTION']; 
  
  
PFUml1=pfu(indexMAXcorr(j)); 
CFUml=cfuUNKNOWN2(j,1)/wellCELLS; 
MOI1=(PFUml1*wellPHAGE)/cfuUNKNOWN2(j,1); 
results1 = sprintf('%1.2e',PFUml1); 
% stringa1 = sprintf('PREDICTION of the pfu/ML:  %s', 
results1); 
%  (stringa1) 
legendINFO{2} = ['PREDICTION of the pfu/ML:  ' results1]; 
  
fprintf('**************PREDICTION FOR THE SAMPLE NUM 
%d!**************\n\n',j) 
  
secondMAX= max((coeff(j,:)<maxCORR(j)).*coeff(j,:)); 
if (abs(secondMAX-maxCORR(j))<=0.04) 
    indexSECMAXcorr=find(coeff(j,:)==secondMAX); 
    ccc=indexSECMAXcorr+(int2(1)-1); 
    
plot(tint,cells(:,indexSECMAXcorr),'color',rgb(colori(ccc))
,'LineWidth',2); 
    PFUml2=pfu(indexSECMAXcorr); 
    MOI2=(PFUml2*wellPHAGE)/cfuUNKNOWN2(j,1); 
    results2 = sprintf('%1.2e',PFUml2); 
%     stringa2 = sprintf('SECOND PREDICTION of the pfu/ML:  
%s', results2); 
%     legappend(stringa2) 
    legendINFO{3} = ['SECOND PREDICTION of the pfu/ML:  ' 
results2]; 
  
    fprintf('PFU/ml prediction: %1.2e - %1.2e 
\n',min(PFUml1,PFUml2),max(PFUml1,PFUml2)) 
    fprintf('CFU/ml prediction: %1.2e \n',CFUml) 
    fprintf('MOI prediction: %1.2e - %1.2e 
\n\n\n\n',min(MOI1,MOI2),max(MOI1,MOI2)) 
  
     
else fprintf('PFU/ml prediction: %1.2e \n',PFUml1) 
     fprintf('CFU/ml prediction: %1.2e \n',CFUml) 
     fprintf('MOI prediction: %1.2e \n\n\n\n',MOI1) 
      
end 
legend(legendINFO) 
    if (maxCORR(j)<0.75 && maxCORR(j)>=0.67) 
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    fprintf('*ATTENTION! THE PREDICTION COULD BE NOT 
PRECISE FOR THIS DATA: SAMPLE NUM %d!*\n\n\n\n',j) 
    end 
  
else fprintf('**************ERROR!! NO PREDICTION FOR THIS 
DATA: SAMPLE NUM %d!**************\n\n\n\n',j) 
end 
pause() 
end 
     
   else  
        fprintf('***ATTENTION! ERROR: NO VALID INPUT. 
Please run the programe again!') 
    end 
end  
     
     
     
     
     
     
     
     
  
 6 Other MATLAB code used: 
 
6.1 rgb.m. 
(http://www.mathworks.com/matlabcentral/fileexchange/24497-
rgb-triple-of-color-name--version-2/content/rgb.m) 
 
6.2 herrorbar.m 
(http://www.mathworks.com/matlabcentral/fileexchange/3963-
herrorbar/content/herrorbar.m) 
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